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Summary	
Polynucleotide kinases (PNKs) are crucial enzymes involved in DNA and RNA repair, RNA 
maturation, as well as in RNA degradation processes. These enzymes have a conserved PNK 
domain, showing structural homology to the classical fold of P-loop kinases. PNKs catalyse 
the transfer of the γ-phosphate group of ATP molecule to the 5’-hydroxyl group of 
polynucleotide substrates. Depending on their in vivo function, PNKs show different substrate 
specificity. Interestingly, eukaryotic PNKs have recently been identified that specifically 
phosphorylate RNA substrates. These novel RNA-specific PNKs constitute the Clp1 
subfamily of PNKs named after their first identified member. Human Clp1 was shown to 
participate in various RNA maturation pathways: (i) cleavage and polyadenylation of RNA 
polymerase II pre-mRNA transcripts, (ii) tRNA-splicing, and (iii) phosphorylation of 
synthetic siRNAs. Despite extensive studies on Clp1, the structural elements involved in 
RNA-specificity and the mechanism of the phosphoryl transfer reaction have remained 
elusive so far. 
This thesis, therefore, aims for the structural and functional characterization of the 
RNA-specific Clp1 PNK. During this work, the three-dimensional structure of Clp1 from 
Caenorhabditis elegans was described for the first time at atomic resolution. Clp1 is a 
multi-domain protein that consists of a central PNK domain sandwiched by additional N- and 
C-terminal domains. Clp1 was crystallized with various RNA substrates that differ in length 
and sequence. Based on these results, the structural features of Clp1’s RNA-specificity were 
elucidated. Clp1 uses an “RNA-sensor” that recognizes the 2’-hydroxyl group of the RNA at 
the ultimate position. Additionally, Clp1 was also crystallized in enzymatically relevant states 
such as an inhibited substrate bound state, a transition state analog and a product bound state. 
A general model for enzyme catalysis of PNKs was derived from these structures. In contrast 
to other described PNKs, Clp1’s ATP-binding site within the PNK domain is obstructed by 
the N-terminal domain. The crystal structures as well as activity assays with truncated 
variants of Clp1 showed a contribution of the N-terminal domain to ATP-binding by 
interactions with the nucleobase. The phosphate groups of the ATP molecule are anchored in 
the active site tunnel, which is formed by the common P-loop motif, a divalent metal cofactor 
(Mg2+), and an α-helical LID module. Structure-guided mutational analysis identified the 
essential role of the Walker A lysine for enzyme catalysis. Moreover, Clp1 crystal structures 
revealed a non-canonical Walker A lysine in an “arrested” conformation that acts as a 




contrast to other nucleotide kinases, Clp1 seems to apply a substrate-gating mechanism that 
prevents futile ATP hydrolysis. In this context, the classical Walker A lysine seems to have a 
so far underestimated regulatory function. Such a molecular switch mechanism of the Walker 
A lysine is not restricted to Clp1 exclusively, since the PDB database provides a significant 
number of crystal structures showing a similar “arrested“ conformation of the Walker A 
lysine. Thus, an additional function of the Walker A lysine as a molecular switch in enzyme 
catalysis is suggested. In conclusion, this thesis provides the first crystal structures of Clp1, 




Polynukleotidkinasen (PNKasen) sind essentielle Enzyme, die in DNA- und RNA-Reparatur-, 
RNA-Reifungs- und RNA-Abbau-Prozessen beteiligt sind. Diese Enzyme besitzen eine 
konservierte PNKase Domäne, die strukturelle Homologie zu den klassischen P-loop Kinasen 
aufweist. Der Reaktionsmechanismus der PNKasen beinhaltet den Transfer der 
γ-Phosphatgruppe von ATP zu der 5’-Hydroxylgruppe eines Polynukleotid-Substrats. 
Abhängig von ihrer Funktion können PNKasen unterschiedliche Substratspezifitäten besitzen. 
Interessanterweise wurden erst kürzlich eukaryotische PNKasen identifiziert, die spezifisch 
RNA phosphorylieren. Diese einzigartigen RNA-spezifischen PNKasen sind Teil einer 
Subfamilie der PNKasen, der sogenannten Clp1 Proteinfamilie. Clp1 war die erste bekannte 
RNA-spezifische PNKase in Eukaryoten und wurde zum Namensgeber dieser neuen 
Proteinfamilie. Es wurde gezeigt, dass humanes Clp1 an verschiedenen 
RNA-Reifungsprozessen beteiligt ist: (i) dem Schneiden und die Polyadenylierung von RNA 
Polymerase II unreifen mRNA Transkripten, (ii) dem tRNA Splicing, und (iii) der 
Phosphorylierung synthetischer siRNAs. Trotz intensiver Studien an Clp1 ist nur wenig 
Mechanistisches über die RNA-Spezifität und den Reaktionsmechanismus des 
Phosphoryl-Transfers von Clp1 bekannt. 
Es war daher das Ziel dieser Doktorarbeit, Clp1 als RNA-spezifische PNKase sowohl 
strukturell als auch funktionell detailliert zu untersuchen. Während dieser Arbeit wurde die 
erste dreidimensionale Kristallstruktur von Clp1 aus Caenorhabditis elegans mit atomarer 
Auflösung bestimmt. Clp1 ist ein Multidomänenenzym mit einer zentralen PNKase Domäne, 
flankiert von einer N- und C-terminalen Domäne. Auf der Grundlage diverser RNA 
substratetratgebundener Strukturen, die sich in Länge und ihrer Seqeuenz der RNA 
unterschieden, wurde ein „RNA-Sensor“ identifiziert, welcher spezifisch die 
2’-Hydroxylgruppe des endständigen Nukleotids erkennt. Zusätzlich konnten in dieser Arbeit 
die enzymatisch relevanten Konformationen des substratgebundenen Zustandes, des 
Übergangszustandes und des produktgebundenen Zustandes beschrieben werden. Mit Hilfe 
dieser Strukturen wurde ein allgemeingültiges Modell des Phosphoryl-Transfer 
Reaktionsmechanismus von PNKasen erarbeitet. Interessanterweise ist im Unterschied zu 
bereits bekannten PNKasen die ATP-Bindungsstelle innerhalb der PNKase-Domäne durch die 
zusätzliche N-terminale Domäne abgeschirmt. Sowohl die strukturellen Ergebnisse als auch 
biochemische Analysen in dieser Doktorarbeit konnten zeigen, dass die N-terminale Domäne 




im katalytischen Zentrum verankert. Das katalytische Zentrum wird von dem bekannten 
P-loop Motiv, einem divalenten Metall-Cofaktor (Mg2+) und durch ein sogenanntes 
α-helikales „LID-Modul“ geformt. Mittels ortsgerichteter Mutagenesestudien konnte die 
essenzielle Rolle des Walker A Lysins für die Enzymkatalyse gezeigt werden. Darüber hinaus 
zeigt die Kristallstruktur von Clp1 eine „arretierte“ Konformation des Walker A Lysins. Das 
Lysin fungiert in Clp1 als ein molekularer Schalter, der erst im Übergangszustand vollständig 
aktiviert wird. Im Gegensatz zu anderen Nukleotidkinasen scheint Clp1 eine Art 
„Gating-Mechanismus“ zu besitzen, welcher nicht-prozessive ATP-Hydrolyse verhindern 
kann. Diese „arretierte“ Konformation des Walker A Lysins übernimmt damit eine 
zusätzliche regulatorische Aufgabe in der Enzymkatalyse. Eine detaillierte Analyse der PDB 
Datenbank identifizierte eine signifikante Anzahl an Kristallstrukturen die ebenfalls ein 
Walker A Lysin in „arretierter“ Konformation besitzen. Mit den Ergebnissen dieser 
Doktorarbeit wird die Funktion des klassischen Walker A Lysins auf die eines molekularen 
Schalters in der Enzymkatalyse erweitert. Insgesamt führten die strukturellen und 
biochemischen Analysen über Clp1 zu neuen Erkenntnissen hinsichtlich der RNA-Spezifität 
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In nature, the chemistry of the 5’-terminus of nucleotides has a strong impact on the fate of 
DNA and RNA molecules. DNA and RNA synthesis reactions rely on nucleoside 
triphosphates, the building block of the nucleotide metabolism1,2. Nucleoside triphosphates 
originate from precursor nucleosides that are activated in a cascade of phosphorylation 
reactions3. Thus, newly synthesized polynucleotides typically bear a triphosphate at their 
5’-termini. The 5’-triphosphate is chemically stable and persists until its removal or 
enzymatic modifications4,5. Interestingly, the phosphorylation state of the 5’-terminus is 
important in various cellular processes. In RNA degradation, the 5’-terminus is specifically 
recognized by both prokaryotic and eukaryotic exonucleases6,7. In both cases mRNA decay 
was initiated after conversion of the 5′-triphosphate (or m7GpppN (7-methylguanosine) cap 
in eukaryotes) to a 5’-monophosphate (5’-phosphate)8,9, whereas in case of mRNA with a 
5’-triphosphate or a 5’-hydroxyl group, mRNA decay was impaired10-16. Furthermore, the 
5’-terminus is also important for enzymes of DNA and RNA repair pathways17,18. These 
repair enzymes require a 5’-phosphate group for an efficient enzymatic activity. Damaged 
nucleotides, however, are characterized by a 5’-hydroxyl terminus that needs to be 
enzymatically processed for efficient repair. Because of the biological relevance of a 
signature 5’-phophate for the nucleotide metabolism, a protein family involved in the 
processing of the 5’-hydroxyl groups is emphasized in this thesis. Polynucleotide kinases 
(PNKs) enzymatically alter the 5’-phosphorylate state of polynucleotides to a 
5’-phosphate. In contrast to the knowledge about PNKs in the DNA metabolism, our 
understanding of their function in RNA maturation and degradation pathways still needs to 
be improved considerably. However, the recent identification of novel RNA-specific PNKs 
(RPNKs) has led to new insights into the field of RNA research. Structural and functional 
characterizations of these RPNKs are very limited and need to be the subject of future 
work. 
 
1.1 Importance	 of	 Polynucleotide	 kinases	 in	 the	 nucleotide	
metabolism	
In general, PNKs have an evolutionary conserved reaction mechanism that catalyzes one of 
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ionizing radiation27 or reactive oxygen species28. However, DNA damage is not necessarily 
linked to stress conditions, since it can also arise during regular cellular processes such as 
DNA replication, recombination, or differentiation29-31.  
Damaged DNA is characterized by a heterogeneous class of lesions including base 
modifications, base excision, and strand breaks29. Exposure of cells to ionizing radiation 
for instance induces elevated levels of hydroxyl radicals, which are chemicals suspected to 
generate DNA single strand breaks (SSB; Figure 1.1.2 A)32. Without end-healing, SSB can 
turn into the most lethal form of DNA damage, the double strand break (DSB; Figure 
1.1.2 A)33. Other sources for DNA lesions are a stalled topoisomerase I after camptothecin 
treatment (Figure 1.1.2 A)34 or nucleases, such as DNase II35,36. Many of these lesions 
leave DNA termini that are unsuitable for subsequent extension or ligation reactions 
mediated by DNA polymerases and ligases. Incompatible DNA-termini are composed of 
3′-phosphate and free 5′-hydroxyl termini17. Repair enzymes however, require a free 
3′-hydroxyl group for a subsequent elongation reaction and, in case of a ligation reaction, 
additional 5′-phosphate termini17. 
To ensure genetic stability, cells rely on a battery of different repair mechanisms 
that are counteracting DNA lesions (Figure 1.1.2 A). The mammalian PNK (mPNK) is a 
multi-functional enzyme that possesses the capacity to both phosphorylate 5′-hydroxyl and 
dephosphorylate 3′-phosphate termini37,38. The mPNK is considered as a key component 
for DNA repair contributing to three different pathways: Base excision repair39, DNA SSB 
repair40 and non-homologous end-joining41. 
Structurally, mPNK is a multi-domain enzyme consisting of an N-terminal FHA 
(forkhead-associated) domain and two spatially separated catalytic domains; a 
3’-phosphatase and a PNK domain42. The FHA domain recognizes phospho-threonine 
residues on specific target proteins42-44 and thereby recruits mPNK to distinctive repair 
complexes45. This active recruitment of mPNK and other DNA repair enzymes protects 
cells against the release of premature intermediates. Interaction partners of the FHA 
domain are the two scaffold proteins, XRCC1 and XRCC4. The SSB repair complex 
(mPNK, DNA polymerase β, and DNA ligase III) is organized by XRCC143, whereas DSB 
repair complex (mPNK, DNA end-binding protein Ku70/80, protein kinase DNA-PK and 
the XRCC4/ligase IV heterodimer) depends on XRCC444. As a key factor for DNA repair, 






The first PNK was discovered 1965 in bacteriophage-infected Escherichia coli 46-48. Since 
then the T4 PNK has become one of the best-characterized PNKs and it is widely used for 
applications in molecular biology49,50 Similar to mPNK, the T4 phage-encoded PNK is a 
multifunctional enzyme composed of an N-terminal PNK domain and a C-terminal 
phosphatase domain51,52. Together with the T4 ligase53, it is shown to be involved in RNA 
repair, enabling the T-even phage to overcome the host’s suicide defense mechanism18 
(Figure 1.1.2 B). In detail, if bacteria encounter a T4 phage infection, the Stp DNA 
restriction inhibitory peptide is activated, which subsequently activates a latent tRNA 
anti-codon nuclease54-56. The active nuclease triggers the lesion of the bacterial lysine 
tRNA, inhibits protein synthesis and thereby phage propagation18. The cleaved tRNA 
molecules have a characteristic free 5’-hydroxyl terminus and, in contrast to DNA repair 
processes, a 2’,3’-cyclic phosphate group18. In order to provide acceptable substrates for 
T4 ligase, T4 PNK phosphorylates the 5’-hydroxyl terminus46 and removes the cyclic 
phosphate group at the 2’,3’-terminus in a two-stage process18,57,58. Subsequently, T4 ligase 
can seal the broken 5’- and 3’-termini of the tRNA59. Notably, T4 PNK and mPNK are 
functionally similar, but they have different polynucleotide specificity. The enzyme 
displays the broadest substrate specificity on DNA and RNA molecules compared to other 
described PNKs60-63. 
Recently, another RNA repair system was also discovered in bacteria repairing 
ribotoxin-cleaved RNAs64. Ribotoxins are proteins responsible for the site-specific 
cleavage of RNA molecules involved in transcription and transition65-67. In contrast to 
classical RNA repair pathways relaying on 5’-phosphorylation and 3’-dephosphorylation, 
this novel system additionally methylates the 2’-hydroxyl group of RNA64 (Figure 
1.1.2 B). Methylated RNA sites are thereby protected against repeated cleavage. The 
enzymatic reaction involves the bacterial Pnkp/Hen1 complex68. Bacterial PNK, Pnkp, is 
composed of three catalytic domains, an N-terminal PNK domain, a central phosphatase 
domain, and a C-terminal ligase domain69, all being required for RNA repair70. The 
presence of RPNKs in bacteria emphasizes the relevance of RNA repair in the prokaryotic 
nucleotide metabolism. This fact might also be true for a eukaryotic pathway. This 
hypothesis became evident just recently with the discovery of several RPNKs, which are 






Besides their functions in DNA and RNA repair mechanism, RPNKs are also involved in 
tRNA maturation71. Intron sequences in tRNA precursor molecules (pre-tRNAs) are found 
in all three kingdoms of life72. To obtain a mature tRNA these intron sequences have to be 
removed by splicing from the pre-tRNAs73. After cleavage by the tRNA-splicing 
endonuclease complex, the intron-cleaved tRNA are composed of a free 5’-hydoxyl group 
at the 3’-exon and a 2’,3’-cyclic phosphate group at the 5’-exon71. To become rejoined into 
a mature tRNA molecule, the 5’- and 2’,3’-termini have to be processed by a 
multi-functional tRNA ligase, named Trl174 that consists of three enzymatic activities in 
functionally independent domains, a cyclic phosphodiesterase domain, a PNK domain, and 
an RNA ligase domain75,76. Trl1 is able to first open the 2’-3’-cyclic phosphate74, than to 
phosphorylate the 5’-hydroxyl terminus74, and finally to rejoin both exon halves to provide 
a mature tRNA molecule74. Interestingly, no homolog Trl1 tRNA ligase was identified in 
higher eukaryotes, suggesting that Trl1 is a distinctive enzyme of yeast tRNA maturation 
pathway (Figure 1.1.2 C).  
However, the signature 5’-phosphate is not only important for sealing reactions by 
ligases. RNA turnover is also controlled by the phosphorylation state of nucleotides at the 
5’-terminus8-16. In contrast to prokaryotes, the mRNA of eukaryotes is modified at the 
5’-terminus, where methylated GMP is incorporated to form the m7GpppN cap5. Despite 
these differences in 5’-capping, the processes in mRNA decay are remarkably similar 
between eukaryotes and prokaryotes. In both cases, the 5′-phosphate represents the 
preferential substrate for nucleases in RNA turnover by exonucleases10-16. In eukaryotes, 
prior to the RNA decay the 5’-cap is hydrolyzed to a 5’-phosphate77,78 Once the 3′-poly(A) 
tail is removed, the mRNA becomes degraded from the 5′-terminus by the 5′-3′ 
exonuclease Xrn179,80 (Figure 1.1.2 C). Furthermore, the signature 5’-phosphate couples 
the specificity of Xrn1 to its processivity7. In prokaryotes, the 5’-triphosphate of the 
mRNA is hydrolyzed to 5’-phoshate8 and the mRNA is subsequently committed to 
degradation by RNase E, an enzyme that recognized the signature 5’-phosphate6 (Figure 
1.1.2 C). In addition, nucleases involved in RNA interference81 (RNAi) also depend on the 
signature 5’-phosphate. Two prominent examples of enzymes that recognize the 
5’-phosphate are the RNA induced silencing complex (RISC)82 (Figure 1.1.2 C) and the 




























Figure 1.1.2. PNK involved in the nucleotide metabolism. A, mPNKs are a recurrent linker for 
repair of different lesion types. B, T4 PNK together with T4 ligase heals lesions of tRNA to 
overcome the host defense mechanism. PNKp-Hen1 complex is involved in a special RNA repair 
pathway that methylates the RNA after ligation to confer protective immunity. C, Trl1 is a 
tri-functional RNA ligase associated with tRNA maturation. The 5’-kinase activity of Trl1 is 
important to re-ligation of the 5’- and 3’-exons to produce a mature tRNA. Efficient mRNA decay 
relies on the presence of a signature 5’-phosphate. The exonucleases Xrn1 and RNase E only 
show efficient enzymatic activity on mRNA substrates with 5’-phosphate group. mRNAs are 
committed to degradation by decapping or removing the triphosphate group (RppH). In addition, 
the signature 5’-phosphate group is also required for siRNAs and miRNAs to become incorporated 
into RISC. Adapted from17,71. 
 
1.2 Clp1,	a	novel	eukaryotic	RPNK	
Since eukaryotic RNA-maturation and RNA-degradation processes strongly rely on the 
presence of 5’-phosphorylated nucleotides, the existence of RPNKs in eukaryotic 
organisms was conceivable. Although this particular enzymatic reaction was already 
described in 1979 in HeLa cell extracts85, characterization of the responsible enzymes 
started only in 200786-88. Human Clp1 (hsClp1) is the first identified eukaryotic RPNK and 
is involved in different RNA maturation pathways; (i) in cleavage/polyadenylation of RNA 
polymerase II transcripts89,90, (ii) in tRNA maturation52,90-92, and (iii) in 5’-phosphorylation 
of synthetic siRNA molecules88,93. 
Eukaryotic Clp1 orthologs display a high degree of evolutionary conservation94. 
Interestingly, Clp1-like PNKs were also identified in plants, archaea and are predicted in 
prokaryotes86,95,96, thereby covering all three kingdoms of life. Based on their sequence 
conservation, these homologous proteins can be grouped into a novel subfamily of PNKs, 
the Clp1 protein family. Despite their structural and sequence similarities, not all 
eukaryotic Clp1 orthologs show 5’-kinase activity. Paradoxically, in contrast to hsClp1, 
Clp1 from Saccharomyces cerevisiae (scClp1) appears to be enzymatically inactive94 and 
functionally different from hsClp1. Consistent with this observation is the fact that hsClp1 
is unable to compensate for the loss of scClp197. Although enzymatically inactive, scClp1 
is still able to bind ATP molecules94,98-100. Thus, it was suggested that ATP-binding might 
be required for structural stability of the protein98-100.  
Since archaeal Clp1 from Pyrococcus horikoshii (phClp1) is enzymatically active95, 
it is conceivable that 5’-kinase activity is ancestral to the Clp1 protein family. scClp1, 
therefore, represents a variant that has lost its enzymatic activity due to distinctive features 















































































































Figure 1.2.1: Proposed function of hsClp1 in mRNA 3’-end processing. A, hsClp1 is part of the 
3’-end processing machinery and required for cleavage and polyadenylation of pre-mRNA. There it 
acts as a bridging factor and interactions Pcf11. B, hsClp1 might has a function in transcription 
termination or mRNA decay by maintaining the signature 5'-phosphate group on the RNA. The 
5‘-nascent transcript already contains a terminal 5’-phosphate after cleavage. This phosphate is 
required for dissociation of the Pol II from the DNA by Xrn2 “torpedo model”104. hsClp1 is 
suggested to maintain this phosphate. Furthermore, hsClp1 might have an additional function in 
maintenance of the 5'-phosphate of mRNAs committed to degradation by Xrn1. Adapted from92. 
 
After identification of hsClp1’s RNA-specific 5’-kinase activity, Martinez and 
Weitzer suggested the involvement of hsClp1 in mRNA degradation88,92 (Figure 1.2.1 B). 
Although the 5’-phosphate is important for efficient degradation by the exonucleases 
Xrn17 and Xrn215, both mRNA and its nascent transcript show no free 5’-hydroxyl 
termini5,105,106. Therefore, it was assumed that Clp1 is involved in maintaining the 
phosphorylation state of the 5’-terminus to counteract putative phosphatases92. This 
hypothesis, however, is in contrast to recent results showing that the 5’-kinase activity of 
hsClp1 is dispensable for mRNA 3′-end cleavage90. Similar to scClp1, hsClp1 seems to 
function only as a scaffold protein in the mRNA 3’- cleavage and polyadenylation 
machinery. Consistent with this assumption is the oberservation that the generation of a 
Clp1-knockout produced a lethal phenotype in mice, but a kinase deficient mutant 
(K127A) was viable90. 
 
(ii) tRNA processing. The endonuclease complex for tRNA-splicing is associated with 
hsClp191. Since hsClp1 was additionally shown to 5’-phosphorylate intron cleaved 
tRNAs88, it is likely that this enzyme is involved in tRNA-splicing (Figure 1.2.2). 
Currently, there are several postulated tRNA-splicing pathways71. However, all of them are 
based on the same underlying principle that splicing of pre-tRNA occurs in two steps: 
cleavage and rejoining of exon halves71. Characteristic ends for this cleavage reaction are a 
5’-hydroxyl terminus and a 2’,3’-cyclic phosphate, respectively71. Apart from the yeast 
ligation pathway, mammals harbor a distinctive pathway that relies on a 2’,3’-cyclic 
phosphate ligase named HSPC117107. This enzyme rejoins the splice site junction by 
ligation of the 2’,3’-cyclic phosphate with a free 5’-hydroxyl group and consequently a 
5’-kinase activity is obsolete for this mechanism71. However, in addition to the 
HSPC117-dependent pathway, a second “yeast-like” pathway is hypothesized, involving a 
PNK (hsClp188,92), a cyclic phosphodesterase108, and phosphotransferease109. However, 
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5'-terminus-healing similar to the yeast-like tRNA-splicing pathway92. Furthermore, recent 
experiments with transgenic kinase-defective Clp1 mice identified a novel tyrosine pre-
tRNA as a substrate of Clp1’s 5’-kinase activity90. Thus, Clp1 from higher eukaryotes 
seems to be involved in the phosphorylation of tRNA 3'-exon halves.  
 
(iii) RNAi. Besides its function in the 3’-terminus processing machinery89 and its role in 
tRNA processing88,90,92, hsClp1 was shown to 5’-phosphorylate synthetic siRNAs in 
vitro88,93 (Figure 1.2.3). The signature 5’-phosphate is required for the incorporation of 
siRNA and miRNAs into RISC111. Although siRNAs and microRNAs already contain a 
5’-phosphate group111,112, Weitzer and Martinez speculated whether hsClp1 or other PNKs 
(Nol9) are involved in the maintenance of this phosphate groups and thereby counteract 
putative phosphatases92. Recent results showed, however that Clp1’s 5’-kinase activity is 
not essential for gene silencing by miRNAs90. 
 
In conclusion, hsClp1 participates in multiple RNA maturation pathways88,90,92. However, 
the 5’-kinase activity seems to be negligible for the function in the 3’-end processing of 
pre-mRNA90. Both scClp1 and hsClp1 are rather functioning as a structural scaffold for 
mRNA maturation. But in contrast to scClp1, hsClp1 is additionally part of the 
tRNA-splicing machinery91 and involved in tRNA maturation88,90,92. 
 
1.2.2 Structural	characterization	of	scClp1	
The three-dimensional structure of the enzymatically inactive scClp1 in association with a 
fragment of its CF IA interaction partner Pcf11 was determined by X-ray crystallography 
at medium resolution (Figure 1.2.4 A and B)94. This analysis revealed a multi-domain 
protein composed of a central PNK domain, sandwiched between additional N- and 
C-terminal domains (NtD and CtD). The NtD (amino-acids 1 to 100) is composed of a 
β-sheet sandwich, whereas the PNK domain (amino-acids 101 to 341) contains the active 
site region of the protein. The PNK domain adopts a classical , fold that is similar to the 
previously described T4 PNK51,52 and the DNA-specific mammalian PNK42 (Figure 1.2.4 
C). Characteristic for the PNK domain are two evolutionarily conserved motifs, the P-loop 
and the Walker B motif113,114. The P-loop is typically found in adenine or guanine 
triphosphate binding proteins19 and it corroborates scClp1’s ability to bind ATP molecules. 




additional NtD94 (Figure 1.2.4 C). Furthermore, the amino acid sequences as well as the 
structural architecture of the proteins suggest that scClp1 and T4 PNK or mPNK have not 
evolved from a common ancestor. The CtD (amino-acids 342 to 446) is folded in a mixture 
of α-helices, -strands and random coils.  
 
1.2.3 The	RNA‐specific	Clp1	protein	family	
Based on recent bioinformatical characterizations of hsClp1, the Clp1 protein family can 
be extended by two newly identified homologs, Nol9 and Grc386,87. These closely related 
proteins also contain a highly conserved P-loop motif, a Walker B motif and were shown 
to be RPNKs86,87. Nol9 and Grc3 are widely conserved eukaryotic proteins and display an 
extensive sequence similarity to the PNK domain of other members of the Clp1 protein 
family, whereas the additional NtD and CtD are less conserved. Interestingly, in the 
archaeal Clp1 homolog the NtD is even missing95. All biochemically characterized 
members (hsClp1, phClp1, Nol9 and Grc3) of the Clp1 protein family were shown to 
phosphorylate a variety of different polynucleotide substrates in vitro, having preference 
for single-stranded RNA as well as double-stranded RNA and DNA substrates86-88,95. 
Therefore, the structural features of the PNK domain seem to define the in vitro specificity 
of the polynucleotide substrate. Despite of this promiscuous RNA-phosphorylation, 
members of the Clp1 protein family contribute specifically to different RNA maturation 
pathways. Exemplarily, Nol9 and Grc3 were shown to be involved in rRNA 
maturation86,87,115,116, whereas hsClp1 is described as a recurrent linker in mRNA and 
tRNA processing88,90,92. This observation might be explained by regulatory functions of 
NtD and CtD. As known for mPNK, the N-terminal FHA domain serves as a 
protein-protein interaction platform that recruits mPNK to its molecular target42. This 
domain-dependent recruitment would explain the distinguishable in vivo substrate 
specificities of hsClp1 compared to Nol9 and Grc3. Furthermore, scClp1 was shown to 
interact with a variety of proteins involved in 3’-end processing, specifically with its 
central domain and the additional NtD and CtD98. However, it remains unclear if these 
additional domains also play a role in enzyme specificity for the enzymatically active 
members of the Clp1 protein family. Therefore, the function of additional domains and the 
identification of putative interaction partners will be of future interest to understand the in 
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However, to fully understand enzyme catalysis of PNKs the knowledge about the nature of 
the transition state is mandatory. So far, structural details of the PNK-catalyzed phosphoryl 
transfer reaction mechanism are missing and need to be further investigated. The transition 
state theory distinguishes between two extreme cases that are characterized by the 
sequence of bond formation and bond breakage of the leaving group120. A dissociative 
transition state is described as a metaphosphate, the bond to the leaving group is fully 
broken and the bond to the nucleophile absent120 (Figure 1.3.1). In contrast to the 
dissociative transition state, the associative transition state shows a penta-coordinated 
leaving group120 (Figure 1.3.1). Depending on the nature of the transition state, charges are 
differently distributed and need to be specifically compensated (Figure 1.3.1). 
Theoretically, the transition state is inaccessible for structural characterization, due to its 
marginal lifetime. Therefore, a special experimental setup is necessary to obtain structural 
information. Instead of capturing the real transition state, compounds are used that mimic 
the transition state geometry and charge distribution121. In several crystal structures 
aluminum fluoride, beryllium fluoride, and vanadate were shown to function as transition 
state analogs for the transferred phosphoryl group122,123. Currently, no structural data of a 
transition state analog in PNKs are available. This information, however, would greatly 
facilitate our understanding of the reaction mechanism and amongst other questions is 
addressed in this work. 
A characteristic feature shared by kinases is an evolutionary conserved P-loop 
motif with the consensus sequence GxxxxGK[S/T]19. The phosphates of the nucleoside 
triphosphate are bound by a hydrogen-bonding network formed by the main-chain amides 
of the P-loop113. The Walker A lysine of the P-loop interacts electrostatically with the 
β- and γ-phosphates in a bifurcated manner113. The metal cofactor (Mg2+) is octahedrally 
coordinated by the conserved Ser/Thr residue, the oxygen atoms of the β- and 
γ-phosphates, and water molecules19. The Walker B is classically composed of a catalytic 
aspartate that activates the acceptor oxygen by deprotonation, a prerequisite for the 
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Therefore, the first aim of this PhD thesis is to gain structural insights into Clp1’s 
substrate specificity by X-ray crystallography. The structural data presented in this 
thesis together with the comprehensive biochemical characterization provide an 
experimental and conceptual framework to understand Clp1’s mode of RNA-recognition 
and RNA-specificity.  
 
The second aim of this thesis addresses Clp1’s mechanism of the phosphoryl transfer 
reaction. Our current knowledge of the phosphoryl transfer reaction and the transition 
state architecture is mainly based on observations made for NMP-kinases. The 
characterization of crystal structures in catalytically important states of Clp1 provides a 
model for the phosphoryl transfer reaction mechanism of PNKs. This model can be applied 
in general since their active sites are highly conserved. Furthermore, based on the crystal 
structure of an active Clp1 ortholog it was possible to identify enzymatically important 
residues that are missing in scClp1.  
 
The third aim was to decipher the function of NtD and CtD in an enzymatically active 
Clp1. As indicated by the crystal structure of the inactive scClp1 ortholog, the central 
domain containing the P-loop motif is sandwiched between additional NtD and CtD with 
unknown functions94. In the case of scClp1, it was shown that these domains are involved 
in protein-protein interactions98. To elucidate the function of these additional domains in 
catalysis, truncated variants of Clp1 were designed and biochemically characterized. Based 
on these experiments, it was possible to show that the NtD is essential for ATP binding, 


















If not otherwise stated, all chemicals were purchased from Carl Roth (Karlsruhe, Germany), 
Fluka (Deisenhofen, Germany), GERBU Biotechnik (Gaiberg, Germany), Honeywell/Riedel 
de Haën (Seelze, Germany), Invitrogen (Paisley, UK), Merck (Darmstadt, Germany), NEB 
(Schwalbach, Germany), Serva (Heidelberg, Germany), and Sigma-Aldrich (Deisenhofen, 
Germany) in analytical grade purity. 
 
2.1.2 Crystallization	screens	
Crystallization screen Company 
Classics Suite Qiagen, Hilden, Germany 
JCSG Core Suites Qiagen, Hilden, Germany 
PEGs and PEGs II Suites Qiagen, Hilden, Germany 
Ammoniumsulfate Suite Qiagen, Hilden, Germany 
Wizard I and II Emerald, Bainbridge Island, WA, USA 
Additive Screen Hampton Research, Alison Viejo, CA, USA 
 




Buffer name Buffer composition 
Lysis buffer 1 20 mM HEPES-NaOH pH 7.0 
100 mM NaCl 
10 mM β-mercaptoethanol 
Lysis buffer 2 20 mM HEPES-NaOH pH 7.0 
100 mM NaCl 
5 mM β-mercaptoethanol 
Anion-exchange buffer 20 mM HEPES-NaOH pH 7.0 
1 mM MgCl2 
2 mM dithioerythritol (DTE) 
Size exclusion buffer 10 mM HEPES-NaOH pH 7.0 
100 mM NaCl 
1 mM MgCl2 
2 mM DTE 
Crystallization buffer 10 mM HEPES-NaOH pH 7.0 
100 mM NaCl 
1 mM MgCl2 
4 mM tris(2-carboxyethyl)phosphine (TCEP) 
Dialysis buffer 20 mM HEPES-NaOH pH 7.3 
100 mM NaCl 
2 mM MgCl2 
4 mM CaCl2 
2 mM DTE 
2x Phosphorylation buffer 100 mM HEPES-NaOH pH 8.0 
200 mM NaCl 
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2x ATPase buffer 20 mM HEPES-NaOH pH 7.0 
200 mM NaCl 
28 mM KCl 
20 mM MgCl2 
1 mM ethylenediaminetetraacetic acid (EDTA) 
0.5 mM nicotinamide adenine dinucleotide 
(NADH) 
0.4 mM phosphoenol pyruvat (PEP) 
SDS-PAGE running buffer 
 
25 mM Tris-HCl pH 8.0 
200 mM glycine 
0.1 % (w/v) sodium dodecyl sulfate (SDS) 
SDS-PAGE separation gel buffer 
 
1.5 M Tris-HCl pH 8.8 
0.4 % (w/v) SDS 
SDS-PAGE stacking gel buffer 1.5 M Tris-HCl pH 6.8 
0.8 % (w/v) SDS 
SDS-PAGE stacking gel (5 %) 125 mM Tris-HCl pH 6.8 
15 % (v/v) Rotiphorese® Gel 30 (37.5:1) 
0.1 % (w/v) ammonium persulfate (APS) 
0.1 % (v/v) tetramethylethylenediamine (TEMED) 
SDS-PAGE separation gel (15 %) 375 mM Tris-HCl pH 8.8 
0.1 % (w/v) SDS 
50 % (v/v) Rotiphorese® Gel 30 (37.5:1) 
0.08 % (w/v) APS 
0.08 % (v/v) TEMED 
10x TBE buffer 
 
890 mM Tris-HCl pH 8.0 
890 mM boric acid 
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RNA-urea gel (9 %) 38 % (v/v) Rotiphorese® 
sequencing gel concentrate (19:1) 
 
52 % (v/v) Rotiphorese® sequencing gel diluent 
1x TBE buffer 
 
0.08 % (w/v) APS 
 
0.08 % (v/v) TEMED 
6x DNA loading dye  
 
30 % (v/v) glycerol 
0.25 % (w/v) bromphenol blue 
0.25 % (w/v) xylene cyanole FF 
5x SDS loading dye  50 mM Tris-HCl pH 7.0 
10 % (v/v) glycerol  
10 % (w/v) SDS 
0.1 % (w/v) bromophenol blue 
0.9 M DTE 
0.1 M β-mercaptoethanol 
RNA-urea loading dye 95 % (v/v) formamide 
 
5 mM EDTA 
 
0.025  % (w/v) SDS 
 
0.25 % (w/v) bromophenol blue 
 
0.25 % (w/v) xylene cyanol FF 
Methylene blue staining solution 0.4 M sodium acetate 
 
2.28 % (v/v) acetic acid 
 




30 mM potassium acetate pH 5.8 
50 mM MnCl2 
100 mM RbCl 
10 mM CaCl2 
15% (v/v) glycerol 
TFB-2 
 
10 mM MOPS-NaOH pH 7.0 
10 mM RbCl 
75 mM CaCl2 
15% (v/v) glycerol 




All bacterial cultures were grown in lysogeny broth (LB) medium. LB-agar plates for single 
colony growth were solidified by addition of bacto-agar. Both LB medium and LB-agar plates 
were routinely provided by the media kitchen of the Max Planck Institute for Medical 
Research (Heidelberg, Germany). Depending on the used E. coli strain and the plasmid 
constructs, different antibiotics were used as selection markers. For growth of E. coli strain 
BL21-CodonPlus(DE3)-RIL, the media was supplemented with 34 μg/ml of chloramphenicol. 
In case of expression experiments, the media additionally contained either 50 μg/ml of 
kanamycin when cells were transformed with pET28b vector or 100 μg/ml of ampicillin after 
transformation with pET21a vector. 
 
Media name Components 
LB 10 g/l bacto tryptone 
5 g/l bacto-yeast extract 
10 g/l NaCl 
Adjusted to pH 7.0 with NaOH 
LB-agar plates 25 g/l Standard-I-nutrient-broth 
15 g/l bacto agar 
 
For selenomethionine labeling of protein, cell cultures of E. coli strain 
BL21-CodonPlus(DE3)-RIL were grown in minimal media supplemented with 
selenomethionine instead of methionine. If not elsewhere stated, cells were treated similar to 
native expression experiments. The media were prepared according to127. 
  




Cells of E. coli strain DH5α were used for plasmid DNA propagation, whereas cells of strain 
BL21-CodonPlus(DE3)-RIL were used for protein overexpression. 
E. coli strains Genotype Reference 
DH5α  F- φ80lacZΔM15 Δ(lacZYA-argF)U169 
recA1 endA1 hsdR17(rk-, mk +) 
phoA supE44 thi-1 gyrA96 relA1 λ- 
128 
 E. coli B F– ompT hsdS(rB– mB–) 
dcm+ Tetr  gal λ (DE3) endA The 






Protein expression of the different construct variants was performed with two plasmids of the 
pET expression vector series (Novagene, Madison, USA). The full-length gene and truncation 
variants thereof were cloned into the multiple cloning sites with the indicated restriction sites.  
The pET28b vector carries both an N-terminal hexahistidine-tag fused to a thrombin 
cleavage site and an optional C-terminal hexahistidine-tag sequence. The expression construct 
was designed with an N-terminal hexahistidine-tag fusion. To prevent an additional C-
terminal hexahistidine-tag, a stop-codon was introduced. In contrast to pET28b, the pET21a 
vector carries only a C-terminal hexahistidine-tag. Both plasmids are isopropyl-β-D-
thiogalactopyranosid (IPTG) inducible expression systems. 
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Name Description Reference 
pET28b T7-based expression system 
coding for a recombinant 
protein of N-terminal 
hexahistidine-tag, a thrombin 
protease cleavage site fused 
to the protein of interest; 
KanR 
Novagene 
pET21a T7-based expression system 
coding for a recombinant 
protein with C-terminal 
hexahistidine-tag; AmpR 
Novagene 
pET28b-ceClp1 Cloned via NcoI/NotI This thesis 
pET28b-ceClp1-K127A Cloned via NcoI/NotI This thesis 
pET28b-ceClp1-K127R Cloned via NcoI/NotI This thesis 
pET28b-ceClp1-W233A Cloned via NcoI/NotI This thesis 
pET28b-ceClp1ΔC104 Cloned via NcoI/NotI This thesis 
pET21a-ceClp1ΔN107 Cloned via NdeI/NotI This thesis 
pET28b-ceClp1ΔC310 Cloned via NcoI/NotI This thesis 






Chemically competent E. coli DH5α and E. coli BL21-CodonPlus(DE3)-RIL cells were used 
for cloning and expression experiments, respectively. Chemically competent cells were 
provided by Maike Gebhard (Max Planck Institute for Medical Research) and produced using 
a modified protocol of Hanahan129. Cells from a glycerol stock were transferred onto an 
LB-agar plate and incubated overnight. A single colony was used to inoculate an overnight 
pre-culture with antibiotics if required. This pre-culture was diluted 1:100 into 0.5 l of LB 
medium. The cell suspension was incubated at 37 °C until an OD600 of 0.5 was reached. 
Afterwards, cells were harvested by centrifugation (6000 x g, 4 °C, 10 min). The supernatant 
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was discarded and the cell pellet was washed with 50 ml of TFB-1. A final centrifugation step 
was performed (6000 x g, 4 °C, 10 min) and the cell pellet was resuspended in 4 ml of TFB-2. 
Aliquots of 50 μl were immediately flash-frozen in liquid nitrogen and stored at -80 °C until 
further use.  
For transformation of E. coli cells with plasmid-DNA, aliquots of chemically 
competent cells were thawed on ice. After thawing, 1-2 µl of plasmid DNA (20-200 ng/μl) 
was added to the aliquot and incubated on ice for additional 15-30 minutes. Cells were heat 
shocked at 42 °C for 45 sec and immediately transferred onto ice for 2-3 minutes. 
Subsequently, 450 μl LB medium was added to the aliquot and incubated at 37 °C for 
60 minutes under constant shaking at 750 rpm in a thermomixer comfort (Eppendorf, 
Hamburg, Germany). Prior to plating, the transformed cells were harvested by centrifugation 
at 4500 rpm in a tabletop centrifuge and resuspended in approximately 50 μl of LB medium. 
This cell suspension was plated on a pre-warmed LB-agar plate supplied with appropriate 
antibiotics. Plates were incubated at 37 °C overnight for single colony growth. 
 
2.2.1.2 Polymerase	chain	reaction	(PCR)	
PCR was used to amplify genetically modified DNA-fragments, taking advantage of build in 
restriction sites within the PCR-primer sequences. A standard PCR protocol was used in a 
TPersonal thermocycler (Biometra, Göttingen, Germany). The protocol was adapted from 
Saiki and colleagues using a thermostable DNA-dependent DNA polymerase130. Primers were 
synthesized by Eurofins MWG Operon (Eurofins, Ebersberg, Germany) and the components 
for the PCR reaction were purchased at New England Biolabs (NEB, Schwalbach, Germany). 
Annealing temperature and elongation time were adapted according to primer characteristics 
and to the particular prduct size, respectively. PCR products were separated by agarose gel 
electrophoresis. These separated DNA fragments were excised and purified by the use of the 
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Component Concentration Volume   [µl] 
PCR template 50 ng/µl 0.5 
Primer 100 pmol/µl 0.5 
Formamide > 99.5 % 3.5 
MgSO4    100 mM 2-4 
dNTPsa 10 mM 5 
10 x Thermopol 
bufferb 
 5 
Vent polymerase 2 U/µl 1 µl 
ddH2O  ad 50 µl 
aMixture of dNTPs containing dCTP, dATP, dGTP and dTTP 





Standard PCR thermocyler protocol 
Program Temperature [°C] Time [min] 
Initial denaturation 95 5 
Denaturation 95 0.5 
Annealing 55 1 
Elongation 68 1 min per 1000 bp 
Final elongation 68 10 
Storage 4 Until further use 








The mutagenesis procedure was carried out according to the QuikChange protocol 
(Strategene, La Jolla, USA). For primer design, an online browser software tool of Agilent 
Technologies (Agilent, Santa Clara, USA) was used and resulting primers were ordered from 
Eurofins MWG Operon (Eurofins Ebersberg, Germany). The QuikChange PCR reaction 
(50 µl) contained 1x Pfu reaction buffer (Stratagene La Jolla, USA), 2.5 μM of each sense and 
antisense primer, 0.2 mM dNTP mix, 50 ng template DNA and 2.5 U Pfu Turbo polymerase 
(Stratagene La Jolla, USA).  
 
In all QuikChange reactions, the following PCR program was used on a TPersonal 
thermocycler (Biometra, Göttingen, Germany):  
 
Site-directed mutagenesis PCR reaction 
Reaction Temperature [°C] Time [min] 
Initial Denaturation 95 5 
Denaturation 95 0.5 
Annealing 55 1 
Elongation 68 1 min per 1000 bp 
Final Elongation 68 10 
Storage 4 Until further use 
Denaturation, annealing and elongation were repeated in 16 cycles. 
 
Annealing temperature and elongation time were adapted according to primer melting 
temperature and the particular plasmid size, respectively. Finally, the reaction sample was 
incubated with DpnI (10 U) at 37°C for 1-2 hours to remove methylated template DNA. 
Subsequently, the nicked PCR product was transformed into chemically competent E. coli 
DH5α cells. Success of site directed mutagenesis was verified by sequencing of the respective 
plasmid DNA from single colonies. 
 




A single colony of E. coli strain DH5α was picked after transformation and used to inoculate 
a 4 ml LB overnight culture at 37 °C. Appropriate antibiotics were supplemented according to 
the selection markers of the used plasmids. Plasmid DNA was isolated according to the 
manufacturer’s instruction using a QIAprep Spin Miniprep Kit (Qiagen, Hilden, Germany). 
Concentration and purity of DNA was determined spectroscopically measuring absorbance at 
260 nm and purity was verified by measuring the 260/280 nm ratio using a NanoDrop 
ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, USA). 
 
2.2.1.5 Restriction	digest	and	ligation	of	PCR	products	
DNA from PCR products or from plasmid DNA was incubated with restriction enzymes 
(NEB, Schwalbach, Germany) for at least 3 hours at 37 °C. To prevent religation, plasmid 
DNA was additionally incubated with 10 U of calf intestine phosphatase (NEB, Schwalbach, 
Germany) at 37 °C for 1 hour. 
 
 
Standard digestion protocol 
Component Concentration Volume [µl] 
DNA ~50 ng/µl xxb 
Restriction enzyme 1 10-20 U/µl 1 
Restriction enzyme 2 10-20 U/µl 1 
BSAb 10 mg/µl 0.5 
10 x NEB buffer  5 
ddH2O  ad 50 µl 
a If necessary, bovine serum albumine (BSA) was added 
b The volume was adjusted to the concentration of the stock solution 
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After restriction digest, samples were either purified with a PCR purification kit (Qiagen, 
Hilden, Germany) or by agarose gel electrophoresis (see. 2.2.1.8) Separated DNA-fragments 
were then purified with a gel extraction kit (see 2.2.1.6; Qiagen, Hilden, Germany). 
 
2.2.1.6 DNA	extraction	from	agarose	gels	
If necessary, DNA bands of interest were excised from the gel with a sterile razor blade and 
the DNA was subsequently extracted using a QIAquick Gel Extraction Kit (Qiagen, Hilden, 
Germany) according to the manufacturer’s instructions. 
 
2.2.1.7 Ligation	reaction	
Ligation reactions were performed according to the manufacturer’s instruction using a 
Rapid DNA ligation kit (Fermentas, St. Leon-Rot, Germany). 
 
Standard ligation protocol 
Component Concentration Amount 
Vector  50-100 ng 
Insert  100-300 ng 
5 x Ligation buffer  4 µl 
T4 DNA ligase 5 U/µl 1 µl 




Agarose gel electrophoresis was used for analysis of DNA molecules that were obtained after 
restriction digest experiments or PCR reactions. Desired DNA molecules were purified in a 
gel containing 1-2 % agarose (w/v). For this, agarose was heated in 1x TBE buffer and cast 
before polymerization. To visualize the DNA under UV light irradiation, ethidium bromide 
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was added prior to solidification to a final concentration of 0.5 μg/ml. Electrophoresis was 
performed in 1x TBE buffer at 70-100 V for 1-2 hours. Samples were supplemented with 
DNA loading dye. As size markers, 1-10 μl of a NEB ruler 1 kb DNA Ladder were used. 
 
2.2.1.9 Sequencing	
To verify successful cloning of the different plasmid constructs, each plasmid DNA was 
sequenced at Eurofins/MWG (Ebersberg, Germany). Sequencing samples contained 
20-200 ng/μl template DNA mixed with sequencing primer in a concentration of 10 μM. The 
sequencing primers used for the respective constructs are listed in the appendix. 
 
2.2.1.10 Cloning	of	full‐length	Clp1	
For generation of the expression construct pET28b-ceClp1, the coding sequence of ceClp1 
was amplified by PCR from Caenorhabditis elegans cDNA (see. 2.2.1.2) According to the 
descriptions for a standard PCR reaction, the coding sequence was amplified using the 
primers ceClp1-pET28b-For and ceClp1-pET28b-Rev. The sequencing primers used for the 
respective constructs are listed in the appendix (see 6.1.1). The sequence of the forward 
primer contained an NcoI restriction site, whereas the reverse primer was designed with a 
NotI restriction site (see 2.2.1.5). The PCR product was purified with a QIAquick PCR 
Purification Kit and subsequently digested with the two restriction enzymes NcoI and NotI. 
The pET28b vector was digested with identical restriction enzymes. After restriction digest, 
both the linearized plasmid DNA and the PCR product were analyzed by agarose gel 
electrophoresis (see 2.2.1.8). The separated DNA-fragments were extracted from the excised 
gel slices using a QIAquick Gel Extraction Kit (see 2.2.1.6; Qiagen, Hilden, Germany). The 
PCR product was cloned into the linearized pET28b vector using a Rapid DNA Ligation Kit 
(Fermentas, St. Leon-Rot, Germany). The ligation leads to an open reading frame (ORF) 
coding for an N-terminal hexa-histidine fusion. For plasmid propagation, plasmid constructs 
were transformed into E. coli DH5α cells (see 2.2.1.1 and 2.2.1.4). 
 




The expression construct pET28b-ceClp1ΔC104 was designed to express a C-terminally 
truncated variant of ceClp1. A stop codon leading to a truncated ORF was introduced by 
site-directed mutagenesis into the pET28b-ceClp1 construct using the QuikChange protocol 
(see 2.2.1.3; Strategene, La Jolla, California, USA). Thereby, the encoding codon triplet of 
residue 105 was mutated to a stop codon using the primer pair ceClp1ΔN104-pET28b-For and 
ceClp1ΔN104-pET28b_Rev. The sequencing primers used for the respective constructs are 
listed in the appendix (see 6.1.1). 
The expression construct pET28-ceClp1ΔC310 was designed as a C-terminal 
truncation of the full-length gene obtained from pET28b-ceClp1. A stop codon was 
introduced into the coding sequence of ceClp1 by site directed mutagenesis using the 
QuikChange protocol (Strategene, La Jolla, California, USA). QuikChange primers were 
designed to replace the codon of residue 310 with a stop codon (ceClp1ΔC310-pET28b-For 
and ceClp1ΔC310-pET28b-Rev). The sequencing primers used for the respective constructs 
are listed in the appendix (see 6.1.1). 
 
2.2.1.12 Cloning	of	N‐terminal	truncations	
The ORF of an N-terminally truncated ceClp1 variant was amplified from the vector 
pET28b_ceClp1 using PCR primers designed with an NdeI and a NotI restriction site. Similar 
to the description for the cloning of the pET28b-ceClp1-Clp1 vector, the truncated coding 
sequence spanning from residue 107 to residue 428 was cloned into a pre-linearized pET21a 
vector (pET21a-ceClp1ΔN107). This ligation leads to an ORF encoding a C-terminally hexa-
histidine fused protein tagged and was kingly provided from Bernhard Dichtl (Zürich, 
Switzerland). 
The expression construct pET21-ceClp1NC314 was designed as an N-terminal 
truncation. Primers for amplification contained an NdeI (ceClp1ΔN314-pET28b-For) and a 
NotI (ceClp1ΔN314-pET28b-Rev) restriction site. This PCR product was digested and cloned 
into a pre-linearized pET21a vector. The ORF encodes for a recombinant protein of 
ceClp1ΔN314 fused to C-terminal hexahistidine tag. The sequencing primers used for the 
respective constructs are listed in the appendix (see 6.1.1). 
 




The expression constructs pET28b_Clp1_K127A, pET28b_Clp1_K127R, and 
pET28b_Clp1_W233A were obtained by site directed mutagenesis based on full-length 
ceClp1. The codon-triplet of residue 127 was replaced with a codon coding either for alanine 
or arginine using the QuikChange protocol (Strategene, La Jolla, California, USA). 
Furthermore, the codon-triplet of residue 233 was also replaced with a codon coding for 
alanine. Primers for site directed mutagenesis were applied on the full-length expression 
construct pET28b_ceClp1 (pET28b_Clp1_K127A_for and pET28b_Clp1_K127Arev; 
pET28b_Clp1_K127R_for and pET28b_Clp1_K127R_rev; pET28b_Clp1_W233A_for and 
pET28b_Clp1_W233A_rev). The sequencing primers used for the respective constructs are 




Proteins were analyzed according to their molecular weight by discontinuous sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE), initially described by Lämmli131. 
For gel casting and electrophoresis, a Protean 4 system (Bio-Rad, Munich, Germany) and a 
PowerPack 200 (BioRad, Munich, Germany) power source were used, respectively. Mini-gels 
were casted in parallel, starting with the separation gel. For the separation gel, 7.3 ml ddH2O 
was mixed with 7.5 ml separation gel buffer and 15 ml aqueous 30 % acrylamide-, 
bisacrylamide (37.5:1, Roth, Karlsruhe, Germany) to obtain a 15 % gel. The polymerization 
reaction was started by addition of 250 μL of 10 % (w/v) APS (Merck, Darmstadt, Germany) 
and 25 μL TEMED (Serva, Heidelberg, Germany). To remove air bubbles, the gel was 
overlaid with isopropanol. To prepare the stacking gel, which was added on top of the 
separation gel, 8.9 ml ddH2O were mixed with 3.8 ml stacking gel buffer and 2.3 ml 30 % 
acrylamide-, bisacrylamide (37.5:1). Polymerization was initiated by addition of 150 μl 10 % 
(w/v) APS and 15 μl TEMED. Gels were stored for up to two weeks at 4 °C until further use. 
Prior to loading, the protein samples were supplemented with 5x SDS PAGE sample buffer 
and boiled at 95 °C for 5-10 minutes. Electrophoresis was performed in SDS PAGE running 
buffer at 35 mA per gel. Gels were stained using Page Blue protein staining solution 
(Fermentas St. Leon-Rot, Germany) and destained with ddH2O. 
 




Large scale protein expression was performed in E. coli BL21-CodonPlus(DE3)-RIL cells 
harboring the respective expression plasmid constructs. LB medium (2 l) was supplemented 
with appropriate antibiotics and inoculated with a 1:100 dilution of an overnight culture. Cells 
were grown until they reached an OD600 of 1.0. Once cells were in their exponential growth 
phase, cultures were cooled down to 18 °C and protein expression was induced by addition of 
1 mM IPTG. Cells were then incubated at 18 °C overnight. After cell harvesting, the pellets 
were resuspended in the appropriate buffers (see 2.1.3) and used either directly for protein 
purification or shock frozen with liquid nitrogen and stored at -80 °C. The bacterial cell wall 




For purification of wild-type ceClp1 and variants obtained by site directed mutagenesis, 
pellets were resuspended in lysis buffer 1. The full-length protein was expressed using 
pET28b vector (pET28b_ceClp1, pET28b_ceClp1_K127A pET28b_ceClp1_K127R, and 
pET28b_ceClp1W233A) and initially purified by metal ion chromatography using Ni2+-NTA 
material (Qiagen, Hilden, Germany). The column (~ 1 ml column volume (CV)) was 
equilibrated with lysis buffer 1 prior to applying the supernatant and subsequently washed 
with 3 CV of lysis buffer 1. Bound proteins were eluted with 6 ml of lysis buffer 1 containing 
additional 300 mM imidazole. To remove the N-terminally fused hexahistidine-tag, the 
protein was cleaved with thrombin (Sigma-Aldrich, Deisenhofen, Germany). For this, eluted 
fractions were dialysed against dialysis buffer overnight and incubated with 80 U of thrombin. 
Cleaved ceClp1 protein was diluted with anion-exchange buffer until a final conductivity of 
5 mS/cm was reached and loaded onto a MonoQ column (GE Healthcare, Freiburg, 
Germany), equilibrated with anion-exchange buffer. Bound proteins were eluted over a linear 
gradient of 30 CV to the anion-exchange buffer containing additional 600 mM NaCl. 
Fractions containing pure ceClp1 were pooled and concentrated using Amicon-15 centrifugal 
filter units (Millipore) with a molecular weight cut-off of 10 kDa. Finally, the protein solution 
was applied onto a Superdex 75 (GE Healthcare, Freiburg, Germany) column equilibrated in 
size exclusion buffer and eluted protein fractions were concentrated as described above. All 
variants generated by site directed mutagenesis were purified accordingly. Protein batches 
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used for crystallization experiments were purified similarly, except that DTE was used in a 
concentration of 4 mM instead of 2 mM, and that it was replaced with 4 mM TCEP in the 
final purification step. 
 
2.2.2.4 Purification	of	truncation	variants	of	ceClp1	
For purification of the N- and C-terminal truncation variants, pellets were resuspended in lysis 
buffer 2. The truncation variants were expressed using pET28b-ceClp1ΔC104, 
pET21a-ceClp1ΔN107, pET28b-ceClp1ΔC310, pET21a-ceClp1ΔN314, and initially purified 
by metal ion chromatography using TALON (Clontech). 
The untagged N-terminal truncated pET21a-ceClp1ΔN107 variant was co-expressed 
with pET28b-ceClp1ΔC104 to improve solubility. Furthermore, pET28b-ceClp1ΔC310 also 
was co-expressed with pET21a-ceClp1ΔN314. The supernatant containing the co-expressed 
truncation variants ceClp1ΔN107 and ceClp1ΔC104 as well as ceClp1ΔC310 and 
ceClp1ΔN314 was loaded on to a TALON Clontech (Saint-Germain-en-Laye, France) metal 
affinity column (1 ml cv) equilibrated with buffer 2. 
After a washing step with buffer 2 the untagged ceClp1ΔN107 was eluted from the 
immobilized ceClp1ΔC104 in a high salt wash of buffer 2 containing additional 1 M NaCl. 
The pooled wash fractions were concentrated using Amicon-15 centrifugal filter units with a 
MWCO of 10 kDa and in a re-chromatography step using TALON Clontech (Saint-Germain-
en-Laye, France) resin, minor traces of ceClp1ΔC104 were removed. A buffer exchange to 
buffer 2 was performed by concentration of the flow-through and re-dilution with buffer 2 in a 
concentration step as described above. The N-terminal domain of ceClp1, the ceClp1ΔC104 
variant was expressed alone and purified over a TALON Clontech (Saint-Germain-en-Laye, 
France) metal affinity column (1 ml cv) equilibrated with buffer 2. After washing with 3 cv of 
buffer 1, the bound protein was eluted with 6 cv of buffer 2 containing additional 150 mM 
imidazole.  
The supernatant of the co-expressed truncation variants ceClp1ΔC310 and 
ceClp1ΔN314 was loaded on to a TALON Clontech (Saint-Germain-en-Laye, France)  metal 
affinity column (1 ml cv) equilibrated with buffer 2. After washing with 3 cv of buffer 2, the 
bound proteins were eluted with 6 cv of buffer 2 containing additional 150 mM imidazole.  
 




5’-kinase activity of ceClp1 towards different RNA and DNA substrates was analyzed 
using a phosphorylation assay. ceClp1 was tested either with a dinucleotide RNA substrate 
guanylyl(3′→5′)cytidine (G1C2) or with RNA and DNA oligonucleotides (20 nt, see 
Appendix 6.1.2). Each reaction was performed under limiting enzyme concentrations (1 µM) 
in 1x phosphorylation buffer.  In case of the G1C2, ceClp1 was incubated with 250 µM ATP 
and 250 µM G1C2 for 2 hours and subsequently the reaction was analyzed by 
chromatographic separation of the products ADP and 5’P- G1C2. In addition, G1C2  (500 µM) 
was also used in a two fold excess relative to ATP to prove that ceClp1 catalysis the 
phosphorylation of G1C2 in a one-to-one molar ratio. Phosphorylation was determined by 
chromatographic purification (see 2.2.2.6). 
For the phosphorylation assay with oligonucleotides, ceClp1 was incubated with 
1 mM ATP and three different RNA and DNA substrates. Oligonucleotides were provided 
either as single-stranded, double-stranded (blunt-end), or double-stranded (3’-overhang) 
substrates. To produce a double-stranded substrate, two complementary strands were mixed in 
equimolar amounts (0.1 mM). For annealing, nucleotide solution was heated to 95°C for 
5 minutes and gradually cooled to room temperature. The resulting double-stranded substrate 
was stored at -20°C until further use. Phosphorylation reactions were incubated at 30 ºC and 
quenched upon addition of 8 M urea. Control experiments were performed with T4 PNK 
(20 U) in an identical experimental setup. Phosphorylation efficiency was determined by 
denaturing PAGE (see 2.2.2.9). 
 
2.2.2.6 Chromatographic	purification	of	the	phosphorylation	products	
This approach is designed for baseline separation of reaction products based on changes of the 
ionic net charge after phosphoryl transfer reaction. After the incubation time of 2 hours, each 
reaction (200 µl) was diluted 1:2 with ddH2O, filtered, and finally applied to a MonoQ 
column (5/50, GE Healthcare, Freiburg, Germany) equilibrated with ddH2O at 4 °C. The 
baseline separation was achieved using a linear gradient to 80 mM NaCl. Under these 
conditions, G1C2 eluted at 5.8 ml, 5’P-G1C2 at 8.7 ml, ADP at 9.2 ml, and ATP at 10.8 ml. 
During chromatographic separation, absorbance at 260 nm and 280 nm and conductivity 
(mS/cm) were monitored.  
 




5’P-G1C2, which is used for a single turnover reverse reaction, was produced enzymatically 
using ceClp1 (see 2.2.2.8). The reaction sample containing 2 μM of recombinant ceClp1 
supplemented with 500 µM of G1C2 and 500 µM of ATP in phosphorylation buffer was 
incubated at 25 °C for 8 hours. After incubation the reaction mixture was diluted 1:2 with 
ddH2O and loaded onto a MonoQ anion exchange column (10/100, GE Healthcare, Freiburg, 
Germany) equilibrated with ddH2O. G1C2 was baseline separated from the phosphorylated 
5’P-G1C2 molecule using a linear gradient of 80 mM NaCl. To prevent contamination from 
residual traces of ADP, an ATP recovery system was used containing pyruvat kinase (PK) 
and 500 µM PEP. Eluted fractions containing 5’P-G1C2 were collected and concentrated using 
a vacuum concentrator. 5’P-G1C2 was resuspended in ddH2O and residual salt was removed 
by gel filtration chromatography. The sample (500 µl) was applied onto a Superdex 75 
column (5/50, GE Healthcare, Freiburg, Germany) and equilibrated with ddH2O. Desalted 
fractions of 5’P-G1C2 were concentrated as described above by a vacuum concentrator and 
stored at -20 °C. 
 
2.2.2.8 Reverse	reaction	
The reverse reaction was analyzed chromatographically under single turnover conditions 
(see 2.2.2.6). The reaction sample contained 60 µM of recombinant ceClp1 supplemented 
with 50 µM of 5’P-G1C2 and 50 µM of ADP in the phosphorylation buffer incubated for 20 
and 40 minutes. Identical to the analysis of the forward reaction, the sample was applied to a 
MonoQ column (GE Healthcare, Freiburg, Germany). To inhibit enzyme activity of possible 
adenylate kinase contaminations, all samples of single turnover reactions were treated with 
100 µM of diadenosine pentaphosphate (Ap5A). Ap5A is known as a potent inhibitor of 
adenylate kinases functioning as a bisubstrate inhibitor132. Based on results obtained from the 
forward reaction, it was shown that ceClp1 5’-kinase activity is not inhibited by Ap5A. 
Additional control experiments were performed to show that ceClp1 protein batches do not 
posses any basal adenylate kinase activity on their own. ceClp1 was incubated with 50 µM of 
ADP. The forward reaction was also performed under single turnover conditions. The reaction 
consisted of 60 µM of ceClp1 supplement with 100 µM of Ap5A, 50 µM of G1C2 and 50 µM 
of ATP incubated for 20 minutes. 
 




Phosphorylation efficiency of ceClp1 towards single-stranded and double-stranded RNA and 
DNA oligonucleotides (20 nt) was analyzed by denaturing Urea-PAGE. For this, 9 % (v/v) 
polyacrylamide gels (19:1 acrylamide to bisacrylamide ratio) containing 8.3 M urea were 
used. Prior to electrophoresis, RNA samples were denatured with urea (4 M) and RNA and 
supplemented with sample buffer. Gels were cast in glass plates (40 cm x 33 cm) with 1 mm 
spacers and were run in 0.5x TBE buffer. Polymerization of the polyacrylamide gel solution 
was initiated by addition of 0.08 % (w/v) APS and 0.08 % (v/v) TEMED. To remove excess of 
APS and TEMED after polymerization, a pre-run step was applied at 25 W for 1 hour. After 
loading, the gel was run at 25 W until G1C2 and 5’P-G1C2 were separated, based on their 
different electrophoretic mobility. RNA and DNA oligonucleotides were visualized by 
methylene blue staining. 
 
2.2.2.10 Steady‐state	kinase	assay	
A coupled colorimetric assay was used to determine consumption of ATP during RNA 
phosphorylation by ceClp1. This assay enables quantification of ceClp1’s kinase activity. 
ATP consumption of Clp1 is coupled to the oxidation of NADH using a recovery system. The 
recovery system consists of two components. The first is PK that converts PEP and ADP to 
ATP and pyruvate, thus responsible for ATP-regeneration. The second is lactate 
dehydrogenase (LDH) that uses pyruvate to produce lactate by using NADH as reducing 
agent. This decrease in the amount of NADH was followed by measuring absorbance change 
at 340 nm and allowed spectroscopical quantification of Clp1’s ATP hydrolysis rates. All 
experiments were performed at constant ATP concentrations of 1 mM. To achieve this, 0.2 
µM of ceClp1 was incubated in ATPase buffer supplemented with 7 U/ml pyruvate kinase 
(Sigma-Adrich, Deisenhofen, Germany) and 10 U/ml lactate dehydrogenase (Sigma-Adrich, 
Deisenhofen, Germany). Prior to the kinetic measurements, the reaction mixture was 
incubated at room temperature for 20 minutes to obtain a stable baseline and subsequently the 
reaction was started by addition of ceClp1. To determine the Michaelis-Menten kinetics for 
the RNA dinucleotide G1C2 and urylyl-(3’-5’)guanosine (U1G2), varying RNA concentration 
were used.  
2 Material and Methods
 
 39
Changes in absorbance at 340 nm were monitored in a 1 cm quarz cuvette (Hellma, 
Mühlheim, Germany) using a JASCO V-650 spectrophotometer. The initial rates of the 






/340    [equation 1.1] 
ΔAbs340:  Difference of absorption at 340 nm 
Δt:   Time-difference (min or s) 
εNADH:   Absorption coefficient of NADH (6220 M-1 cm-1) 
cp:  Protein concentration (M) 
d:   Path length of cuvette (cm) 
 
Initial rates were plotted against the substrate concentration and fitted using the standard 




 max     [equation 1.2] 
 
S:  Substrate concentration 
vmax:  Maximal apparent reaction velocity 
Km:  Apparent Michaelis-Menten constant 




vK     [equation 1.3] 
cp:   Protein concentration (M) 






Protein stability of wild type ceClp1 and mutant variants was compared using CD 
spectroscopy. Melting curves were determined using  change in ellipticity at 222 nm from 
10°C to 60°C with a heat-rate of 0.5 °C/min. Protein samples (15 µM) in size exclusion buffer 
were analyzed using a Jasco J-810 spectropolarimeter (Jasco, Groß-Umstadt, Germany) with 
1 mm CD cuvettes (Hellma, Müllheim, Germany). 
 
2.2.4 Crystallographic	Methods	
To identify suitable crystallization conditions, protein solution was pre-mixed with nucleotide 
ligands and applied to a variety of crystallization screens in a 96-well plate sitting drop vapor 
diffusion setup with the Mosquito nanolitre pipetter (TTP LabTech LTD, Melbourn, UK). 
Manual optimization in Linbro plates using the hanging drop vapor diffusion method was 
unsuccessful. For this, crystallization conditions were optimized in 96-well plates. Prior to 
flash cooling in liquid nitrogen, crystals were transferred with a cryo-loop into a 
cryo-protectant solution.  
 
2.2.4.1 Crystallization	and	cryo‐protection	
Initial crystallization trails were performed with full-length ceClp1 (450 μM) crystallized in 
the presence of 1.5 mM adenyl-5’-(,-imido)triphosphate (AppNHp, Jena Bioscience, Jena, 
Germany) and 1.5 mM G1C2 or ADP and 1.5 mM G1C2 or 1.5 mM of ATP in a three-fold 
excess compared to the protein concentration. Crystals were obtained at 20 °C using the 
sitting drop vapor diffusion method with a reservoir solution composed of 100 mM 
Na2HPO4/KH2PO4 between pH 5.0 and 6.0, 200 mM NaCl, 15 mM MgCl2, 90 mM sarcosine 
and 25 % (w/v) polyethylene glycol (PEG) 1000. All crystals that were obtained under the 
described condition were suitable for soaking experiments. To ensure full occupancy of the 
soaked ligands, ligand concentration was increased to 10 mM in the cryo-protectant. An 
artificial apo structure of ceClp1 was obtained by soaking of a ternary complex 
(ceClp1•ATP•Mg2+) with mother-liquor containing alkaline phosphatase solution. The 
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inhibited substrate bound state was obtained after incubation of ceClp1 with 10 mM G1C2 or 
U1G2 and 10 mM AppNHp (ceClp1-AppNHp-G1C2 and ceClp1-AppNHp-U1G2). The 
transition state analog (ceClp1-ADP-AlF4--G1C2) was obtained after soaking with 10 mM 
ADP and G1C2 dinucleotide and aluminum fluoride. AlFX was generated in situ by addition of 
20 mM NaF and 5 mM AlCl3. In order to obtain crystals bound to ATP (ceClp1-ATP), 
crystals grown in the presence of ADP and subsequently incubated with 10 mM ATP. 
Residual traces of ADP were removed upon addition of a recycling system that converts ADP 
to ATP (PK and PEP). Crystals bound to the G1A2A3A4 tetra-nucleotide (ceClp1 RNA 4mer) 
were obtained by soaking with 10 mM ADP and 5 mM tetra-nucleotide. Finally, crystals 
bound to their educts were obtained by incubation with 10 mM ATP and G1C2 dinucleotide 
(ceClp1-ADP). The crystallized protein was still enzymatically active. However, those 
crystals appeared to have slightly suffered from incubation (max. resolution of 2.6 Å) but 
were virtually identical to crystals soaked with 10 mM ADP and 100 mM MgCl2 (max. 
resolution of 2.1 Å). For flash cooling in liquid nitrogen, crystals were cryo-protected by 
addition of 5 % (v/v) PEG 600 and 2.5 % (w/v) sucrose to their respective soaking solutions. 
In order to identify the position of the catalytic divalent ion by, Mg2+ was replaced by Mn2+ in 
the ATP bound structure. 
 
2.2.4.2 Data	collection	
Diffraction data were collected at 100 K either at the synchrotron beamline X10SA at the 
Swiss Light Source (SLS) in Villingen, Switzerland or in-house at the Max Planck Institute 
for Medical Research. All data sets were processed with the XDS package 133. Diffraction 
data were indexed and integrated with XDS and scaled and merged with XSCALE. 
XDSCONVERT was used to convert files into a format compatible with the programs used 
for phasing, model building, and refinement. For calculation of a free R-factor, 5 % of 
reflections from diffraction data sets were randomly assigned and excluded from refinement. 
 
2.2.4.3 Structure	determination	
Experimental phases for ceClp1 were obtained from a single anomalous diffraction 
experiment on selenomethionine-labelled protein crystals and experimental phases were 
obtained using SHELX134. An initial model for ceClp1 was built manually using COOT135 
and refined with CNS136. Phase extension to a high-resolution native ceClp1 data set was 
2 Material and Methods
 
42 
performed following a rigid-body refinement protocol in CNS136. In later stages of ceClp1 
structure refinement, iterative cycles of refinement using REFMAC137 including TLS 
refinement138 were performed, followed by manual model improvement using COOT135. 
Water molecules were assigned manually. Phases for different nucleotide-bound forms of 
ceClp1 were obtained by rigid-body refinement137 with the refined structure of 
selenomethionine-labelled ceClp1, followed by cycles of manual model improvement and 
refinement using REFMAC137 including TLS refinement138. Intermediate and final structures 
were evaluated with MOLPROBITY139 and PROCHECK140. All figures were drawn using 




Multiple sequence alignments were generated with ClustalW software 
(http://www.ebi.ac.uk/Tools/msa/clustalw2) and secondary protein structure predictions were 
obtained by the PSIPRED tool (http://bioinf.cs.ucl.ac.uk/psipred/). Sequence alignments were 




The interaction interface between ceClp1 and cePcf11 was deduced by superposition of the 
previous provided crystal structure of scClp1 bound to scPcf1194 (PDB 2NPI) and the crystal 
structure of ceClp1 (ceClp1-AppNHp-G1C2). Structures of both orthologs were superimposed 
by secondary-structure matching and the peptide representing scPcf11 was mutated according 
to a sequence alignment between scPcf11 and cePcf11. Side-chain geometry of cePcf11 was 
optimized to avoid steric clashes with the structure model of ceClp1. All modeling steps were 
performed by COOT software135. The superposition of individual polypeptide chains was 







This chapter presents crystallization and subsequent structure determination of Clp1 by X-ray 
crystallography, providing the first three-dimensional structures of a eukaryotic, RPNK. 
ceClp1 was crystallized in complex with various RNA substrates that differ in length and 
sequence. The molecular basis of RNA-recognition and RNA-specificity were investigated 
using these RNA bound crystal structures. In addition, Clp1 was crystallized at important 
states of its catalytic cycle providing new insights into the phosphoryl transfer reaction 
mechanism of PNKs.  
 
3.1.1 Bioinformatical characterization of the Clp1 protein family 
In contrast to enzymatically inactive scClp194, the human ortholog functions as a 5’-PNK88. 
Furthermore, hsClp1 is the first identified eukaryotic PNK that is specific for single stranded 
RNA rather than DNA substrates85,92. Unfortunately, hsClp1 is insoluble (Bernhard Loll, 
personal communication) and thus unsuitable for crystallization experiments. This 
necessitated the search for other enzymatically active orthologs that could be used for 
crystallization experiments. The amino acid sequences of Clp1 orthologs from a 
representative selection of eukaryotic organisms were analyzed by multiple structure-based 
sequence alignment (Figure 3.1.1). The aim of this bioinformatical characterization was to 
identify conserved structural features that might be specific to enzymatically active variants of 
Clp1. 
Characteristic for the entire eukaryotic Clp1 protein family is the common P-loop 
motif (phosphate-binding loop) and the Walker B motif113,114. The P-loop motif consists of a 
flexible loop between strand β10 and helix α2 and shows the consensus sequence 
GxxxxGK[S/T] (Figure 3.1.1). The distal Walker B motif consists of a conserved aspartate 
residue located after strand β11. The P-loop and the Walker B are involved in substrate 
binding and enzyme catalysis19,113. Inspection of multiple sequence alignment within higher 
eukaryotes revealed two additional conserved motifs. 
The first constitutes the LID module, a mostly helical structure located within α7, 




The LID module contains the conserved RxxxxR sequence and was suggested to stabilize the 
transition state by neutralizing emerging negative charges of the transferred phosphoryl group 
as known for other P-loop kinases118. A comparison of orthologs from higher eukaryotes with 
Clp1 from fungi revealed that both or at least one of the conserved arginine residues is 
replaced by hydrophobic amino acids (Fig. 3.1.1). The second motif, the clasp, has the 
consensus sequence TxGW and plays a major role in RNA-binding. In contrast to higher 
eukaryotes, yeast orthologs showed no conservation of the clasp motif. 
The low sequence conservation of Clp1 from fungi compared to higher eukaryotes 
suggests that scClp1 has lost its enzymatic activity during evolution by distinct mutations. 
ATP-binding by the P-loop motif, however, remained unaffected94,98-100. Orthologs from 
higher eukaryotes, in contrast, show high sequence conserved within the four critical motifs 
(Figure 3.1.1). Thus, it is most likely that orthologs from higher eukaryotes function in a 
similar way as shown for hsClp1. Interestingly, ceClp1 carries a unique insertion in the loop 
region connecting the NtD with the PNK domain. Since this insertion might have a positive 
affect on Clp1’s protein solubility, the protein was purified and subsequently applied to 
structure determination experiments. ceClp1 has the highest homology to Clp1 from Xenopus 
laevis with a sequence identity of 78.7 %. However, it also shows a significant homology to 
both, hsClp1 and Clp1 from Drosophila melanogaster, with a sequence identity of 48.0 % and 
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100 mM Na/K phosphate buffer pH 6-7, 200 mM NaCl, 15 mM MgCl2, and 90 mM sarcosine 
(Figure 3.1.3 B). Crystal growth was achieved only with a 96-well plate, while up-scaling into 
a 24-well plate format (Linbro plates) remained unsuccessful. During crystal harvesting, a 
cryo-protection solution was used preventing ice formation during flash-cooling in liquid 
nitrogen. This cryo-protectant consisted of mother-liquor with additional 5 % (v/v) PEG 600 
and 2.5 % (w/v) sucrose. The cryo-protectant solution was supplemented with AppNHp and 
G1C2 at the same concentration as used for co-crystallization in order to avoid substrate 
diffusion from the active site of the protein crystals. Based on diffraction data obtained from 
the crystals, an electron density map was generated showing both a bound AppNHp molecule 
and a Mg2+ ion in the active site (ceClp1-AppNHp-Mg2+), whereas no electron density for the 
RNA molecule was observed. 
The crystal structure of ceClp1-AppNHp-Mg2+ revealed that crystallization of ceClp1 
depends on the presence of a nucleoside triphosphate, whereas presence of G1C2 during 
crystallization experiments was not required. Thus, ceClp1 was also co-crystallized with a 
three-fold excess of ATP (1.3 µM) or ADP (1.3 µM) using the same precipitant conditions as 
described for growth of ceClp1-AppNHp-Mg2+ crystals. In both cases crystals started to grow 
after one day. However, no electron density for the Mg2+ ion was observable for the ceClp1-
ADP complex. Increasing the MgCl2 concentration in the cryo-protectant up to 100 mM 
finally enabled Mg2+ incorporation, leading to a ternary complex of ceClp1 (ceClp1-ADP). 
Since hsClp1 was shown to use different divalent metal cofactors85, Mg2+ and Mn2+ were 
tested for crystallization experiments. Crystals co-crystallized with ATP were transferred to a 
cryo-protectant solution in which MgCl2 was replaced with 15 mM of MnCl2 (ceClp1-ATP). 
Furthermore, in these experiments a ATP recycling system was added to the cryo-protectant 
to remove residual traces of ADP arising from spontaneous ATP hydrolysis. This recycling 
system consisted of PK that converts ADP to ATP using PEP as substrate. The crystals were 
transferred to the cryo-protectant solution and incubated for 30 minutes. In contrast to soaking 
experiments, in which no recycling-system was added, a mixture of ADP/ATP was observed 
in the electron density map. To identify ceClp1’s in vivo substrate, attempts to crystallize 
ceClp1 with double stranded DNA duplexes or with an RNA anti-codon loop analog were 

















































ted in a te
n that the c
allized (pH
m of the c




l, 15 mM M


















































 mM Na/K 




















































, 100 mM Na



















n the pH at
roaluminat
sphate buff
, 200 mM 
 


















 as a tran
th 5 mM A
ce it was 
, which the
e (AlF3))146

























































90 mM sarcosine). Furthermore, soaking experiments were performed with pH ranging from 
8 to 9, in order to induce formation of an AlF3 transition state analog. However, at high pH it 
was impossible to trap a mimic and no AlF3 was bound. 
Based on the electron density map, it is not possible to distinguish between an AlF-4 
and a tetrafluoromagnesate (MgF42-) transition state analog147. Since both analogs would have 
been possible, two control soaking experiments were performed without AlCl3. Both 
experiments differed in the type of the divalent metal cofactor. The 100 mM MgCl2 of the 
cryo-protectant solution of the first experiment were replaced with 100 mM of MnCl2 for the 
second experiment. Capturing of the transition state analog without AlCl3 would indicate the 
existence of an MgF42- or tetrafluoromanganate (MnF4) transition state analog in the active 
site of ceClp1. Furthermore, a transition state analog formed by MnF4 could easily be 
identified by an anomalous scattering signal of the manganese atom. However, no electron 
density for a transition state analog for MgF42- and MnF4 was obtained, suggests that indeed 
AlF4- was bound. Additionally, another trial was performed aiming for capturing the transition 
state analog using G1A2A3A4. Previous observations with the transition state mimic suggested 
full occupancy of the RNA-binding site at much lower concentrations during a transition state 
as compared to a substrate bound state. The cryo-protectant was, therefore, supplemented with 
5 mM of G1A2A3A4. Analysis of crystals soaked under these conditions showed no transition 
state analog, instead those crystals resemble a product bound state (ceClp1-4mer).  
Additionally, soaking experiments showed that ceClp1 remains enzymatically active 
within the crystal. To obtain crystals captured with their educts, cryo-protectant was 
supplemented with a ~25 fold excess of ATP and G1C2. Analysis of the diffraction data from 
those crystals showed reaction product formation (ADP) in the electron density map, whereas 
phosphorylated RNA was missing. These structures were virtually identical to the 
ceClp1-ADP crystal. Since turnover crystals appeared to have slightly suffered from 
incubation (max. resolution of 2.6 Å), the ceClp1-ADP structure (max. resolution of 2.1 Å) is 
referred to as RNA released product bound state. 
All diffraction data were collected either at the PXII beamline at the SLS in Villigen, 
Switzerland, or in-house using a Rigaku MicroMax 007 HF microfocus X-ray generator. 
Space group, unit cell parameters, and the overall Wilson B-factor are given in Table 3.1.1. 





3.1.4 De novo phasing of ceClp1 by single-wavelength anomalous diffraction 
experiments	
Experimental phases of ceClp1 were obtained by de novo phasing using a single-wavelength 
anomalous diffraction (SAD) experiment148. To obtain selenomethionine labeled protein, 
Clp1 was overexpressed similar to native protein, except that cells were grown in minimal 
medium, in which the amino acid methionine was substituted with its seleno-derivate127. 
Protein with incorporated selenomethionine was purified (see 2.2.2.3) and crystallized similar 
to the native protein. Precipitant conditions were similar to the description for native protein 
(22 % (w/v) PEG 1000, 100 mM Na/K phosphate buffer pH 6-7, 200 mM NaCl, 15 mM 
MgCl2, and 90 mM sarcosine). Flash-cooling was achieved with a cryo-protectant containing 
the mother liquor supplemented with 5 % (v/v) PEG 600, 2.5 % (w/v) sucrose, 1.3 mM 
AppNHp, and 1.3 mM G1C2 (ceClp1-SeMet). A highly redundant data set from 
selenomethionine crystals that diffracted up to 2.3 Å resolution was collected at the 
absorption edge of selenium. Collected diffraction images were indexed, integrated, and 
scaled using the XDS package133. 
The positions of the selenium atoms were localized and native phases were determined 
using SHELXD149 and SHELXE134, respectively. The SHELX programs are embedded in the 
graphical user interface HKL2MAP that facilitates usage150. SHELXD identified 11 selenium 
atom positions with a correlation coefficient of 31.2 % (all) and 17.9 % (weak) as the best 
solution. The pseudo-free correlation coefficient, which is calculated by randomly leaving out 
10 % of the reflections, was 54 %. 
Similar to the observations made for native crystals, the SeMet-Clp1 crystals belong to 
the trigonal crystal system and have the space group P31. The crystals contain one molecule 
per asymmetric unit. Seven selenomethionine positions could unambiguously be identified 
and were used to calculate an initial electron density map. An initial model for ceClp1 was 
manually built using COOT135 and refined with CNS136. In later stages of ceClp1 structure 
refinement, iterative cycles of refinement were performed using REFMAC137 including TLS 
refinement138 with manual model improvement using COOT135. They led to a final Rwork and 





3.1.5 Phasing and refinement of the different ceClp1 complexes 
Diffraction data of the different nucleotide free-/bound-forms of ceClp1 were processed with 
the XDS package133 and phases were obtained by rigid-body refinement137 using the refined 
model of selenomethionine-labelled ceClp1 as a starting model. Once phases were calculated, 
models were manually improved by COOT135 and subsequently refined using REFMAC137 
with restrained maximum likelihood refinement including TLS refinement138. Water 
molecules were assigned manually. Data collection and refinement statistics are summarized 
in Table 3.1.1. 
 
3.1.6 Crystal structure of apo-ceClp1	
The overall architecture of ceClp1 can be subdivided into three distinct domains, a central 
PNK domain flanked by additional N- and C-terminal domains (NtD and CtD, Figure 3.1.4 A 
and B). Diffraction data of the apo-structure had a maximum resolution of 2.1 Å. The 
structure model was refined to an R-factor of 18.8 % with an Rfree of 23.2 % (Table 3.1.1; 
ceClp1-apo). Based on the electron density map, a continuous polypeptide chain starting at 
residue 4 and ending at residue 425 could be modeled. Only two unassigned loop regions 
from residue 105 to residue 111 and from residue 331 to residue 349 could not be modeled 
due to ambiguous electron density. Furthermore, the electron density map revealed the 
presence of two inorganic phosphate molecules (Pi). One Pi is bound to the P-loop motif, 
positioned at the expected location of β-phosphate of an ATP molecule113. The other Pi is 
bound to an arginine residue (Arg406) at the molecular surface of the protein. There was also 
additional density observed for a PEG molecule, which was at a van der Waals distance to a 
hydrophobic patch on the surface of ceClp1 (composed of residues Trp62, Leu88, His91, 
Try137, and Arg140). 
The PNK domain is the central domain of the ceClp1 structure, spanning from residue 110 to 
residue 310. It contains the active site region, and the fold of the PNK domain is structurally 
related to T4 PNK (r.m.s.d.: 3.1 Å)51,52. The PNK domain of ceClp1 is composed of an α/β 
fold also called Rossmann fold151. Characteristic for the Rossmann fold is a central β-sheet 
flanked by α-helices. The central β-sheet has a topological arrangement of four parallel 
strands in a 4-1-3-2 order, similar to the previously described T4 PNK51,52. A diagram 
describing the topological arrangement of secondary structures within ceClp1 is presented in 




leading to a seven-stranded central β-sheet. Whereas the PNK domain is structurally 
conserved and related to members of the kinase protein family19, the additional NtD and CtD 
constitute novel structural features. A structural comparison of this domain from ceClp1 with 
the PBD database using the DALI server152 revealed the greatest structural similarities 
between ceClp1 and the yeast ortholog94. 
 
Table 3.1.1 X-ray diffraction data collection and refinement statistics of ceClp1. 
Data collection     
Data set ceClp1-SeMet ceClp1-ATP ceClp1-ADP ceClp1-AppNHp-G1C2 
PDB entry     
Space group P31 P31 P31 P31 
Unit cell (a,b,c [Å]) 100.7, 100.7, 40.3 99.3, 99.3, 40.8 100.0, 100.0, 40.4 100.4, 100.4, 40.3 
Wavelength [Å] 0.9786 0.9793 0.9792 0.9786 
Resolution [Å] a 50-2.3 (2.4-2.3) 50-2.3 (2.4-2.3) 50-2.0 (2.1-2.0) 50-2.0 (2.1-2.0) 
No. reflections a 40589 (3026) 19707 (2323) 30056 (4086) 30691 (7581) 
Completeness [%] a 99.7 (99.5) 98.5 (97.0) 98.6 (99.1) 99.9 (99.8) 
<I/(I)> a 13.2 (2.9) 12.4 (4.8) 14.8 (2.4) 17.2 (3.8) 
Rmeas a, b 9.6 (57.6) 8.5 (33.4) 5.8 (59.9) 6.2 (46.7) 
Redundancy  4.8 (4.7) 3.6 (3.6) 3.5 (3.5) 4.4 (4.3) 
Refinement     
Rwork a, c 19.2 (32.9) 18.2 (22.3) 19.1 (43.6) 18.2 (28.8) 
Rfree a, d 24.0 (42.4) 23.5 (35.4) 24.2 (47.6) 22.8 (31.1) 
Overall B factor [Å2] 31.5 39.8 38.1 36.2 
Wilson [Å2] 43.8 46.1 45.8 42.1 
r.m.s.d. e from ideal 
geometry: 









bond angles [°] 1.312 1.275 1.135 1.290 
Ramachandran 
statistics: 
    
allowed [%] 92.3 92.1 91.8 92.1 
additionally allowed 
[%] 





Table 3.1.1 X-ray diffraction data collection and refinement statistics of ceClp1. 
Continue. 
 
a values in parentheses refer to the highest resolution shell 
zb Rmeas = h [n/(n-1)]1/2 i  Ih - Ih,i/ hi Ih,i.where Ih is the mean intensity of symmetry-equivalent 
reflections and n is the redundancy. 
c Rwork= h Fo – Fc/  Fo (working set, no  cut-off applied) 
d Rfree is the same as Rwork, but calculated on 5% of the data excluded from refinement. 
e root-mean-square deviation (r.m.s.d.) from target geometries. 









PDB entry     
Space group P31 P31 P31 P31 
Unit cell (a,b,c [Å]) 99.7, 99.7, 40.8 100.7, 100.7, 40.4 100.7, 100.7, 40.3 99.42, 99.42, 
40.40 
Wavelength [Å] 0.9786 1.5418 0.9782 0.9792 
Resolution [Å] a 43-2.4 (2.5-2.4) 50-2.2 (2.4-2.2) 43.6-2.1 (2.2-2.1) 49.7-2.3 (2.4-2.3)   
No. reflections a 17640 (2001) 22553 (2442) 26620 (3434) 19795 (2374) 
Completeness [%] a 99.6 (99.1) 96.9 (83.7) 99.9 (99.8) 99.7 (99.7) 
<I/(I)> a 17.9 (2.7) 18.9 (7.0) 12.62 (4.44) 17.34 (3.46) 
Rmeas a , b 6.8 (56.4) 5.9 (22.7) 14.0 (48.2) 5.5 (41.8) 
Redundancy  3.9 (3.7) 3.1 (3.0) 6.0 (5.3) 3.51 (3.59) 
Refinement     
Rwork a, c 18.5 (34.7) 22.7 (56.2) 20.2 (41.3) 19.0 
Rfree a, d 21.9 (35.9) 28.0 (57.7) 25.0 (40.7) 23.3 
Overall B factor [Å2] 34.1 26.5 21.9 35.1 
Wilson [Å2] 58.1 36.8 42.0 40.0 
r.m.s.d. e from ideal geometry: 
bond length [Å] 
0.013 0.009 0.010 0.010 
bond angles [°] 1.355 1.155 1.330 1.090 
Ramachandran statistics:     
Allowed 92.4 91.7 92.4 96.3 




Besides this structural conservation, the PNK domain of ceClp1 also showed a significant 
structural homology to a signal recognition particle GTPase153 (Z-score 10.8, r.m.s.d.: 2.6 Å, 
and a sequence identity of 16 %; PDB accession code: 2J7P, chain: B). 
The NtD covers residues 4 to 105 and is composed of a sandwich of two β-sheets. The 
electron density map did not allow modeling of the first three amino acids, suggesting that 
they are disordered. In contrast to the PNK domain, a DALI-server search152 in the PDB 
database revealed no significant similarity to any solved structure. The most similar fold 
identified was Mif2p, a conserved DNA-binding kinetochore protein154 (Z-score 8.4, r.m.s.d.: 
1.8 Å, and 12 % sequence identity, PDB; accession code: 2VPV, chain: B). 
The CtD is slightly larger than the NtD and encompasses residues 311 to 425, folded 
in a mixture of β-strands and random coils. For the CtD, a PDB database search152 revealed 
low structural homology to the α-subunit of an ATP synthase155 (Z-score: 4.5, r.m.s.d.: 2.5 Å, 
and a sequence identity of 9 %; PDB accession code: 3OEH, chain: T). Based on previously 
presented structural data of yeast Clp1 (scClp1), it was shown that the interface between the 
central PNK domain and CtD is involved in binding of Pcf1194. Pcf11 together with scClp1 
are subunits of the cleavage factor CF IA involved in the 3’-end processing machinery of 
eukaryotic Pol II transcripts102. 
Based on a sequence alignment, the active site region of ceClp1 at the PNK domain 
can be divided into an ATP- and an RNA-binding site that contains four recognizable 
structural motifs associated with substrate binding and enzyme catalysis (Figure 3.1.1). The 
most prominent motif for kinases is the P-loop sequence 121GxxxxGKT128. Besides the 
P-loop, ceClp1 contains a Walker B motif 151DxxQ154, and two motifs that are only conserved 
among Clp1 family members of higher eukaryotes. These motifs are a LID module 
288RxxxxR293 and a clasp 230TxCGW233. To structurally characterize the substrate binding 
properties of ceClp1, crystals of the complex were generated by soaking with AppNHp, Mg2+ 
and G1C2 (inhibited substrate bound state) or by co-crystallization with ATP-Mn2+ (substrate 
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RNA were clearly visible and were found to bind to the conserved clasp comprising the 
consensus sequence TxGW. On the one hand, the indol function of the tryptophan residue 
(Trp233) mimics a base stacking interaction to the ultimate base (G1) and provides an initial 
platform for RNA-binding (Figure 3.1.5 A). On the other hand, the penultimate base (C2) is 
stacked against G1, thereby perfectly sandwiching G1 between the side chain of Trp233 and 
C2 in a clasp-like binding mechanism. Apparently, G1 gets locked by Trp233 and C2. This 
observation suggests that ceClp1 requires two bases as minimal substrate length for efficient 
binding (see 3.2.2). G1 gets locked to the Trp233 binding platform only in the presence of a 
second base. 
Another interaction between clasp and RNA substrate is mediated by the main-chain 
amide of a glycine residue (Gly232) (Figure 3.1.5 A). Gly232 forms a hydrogen bond to the 
5’-hydroxyl group of the ultimate ribose. The 5’-hydroxyl group is also recognized by 
catalytic aspartate of the Walker B motif (Asp151), forming an additional hydrogen bond. 
These interactions most likely are involved in the correct positioning of the RNA substrate. 
The free 5′-hydroxyl group of RNA points towards the γ-phosphate of the ATP molecule, as 
expected for an in-line mechanism52. 
ceClp1 also interacts with the oxygen atoms of the bridging phosphate backbone. A 
glutamine residue Gln154 forms a hydrogen bond to an oxygen atom of the phosphate group. 
Furthermore, guanidinium groups of Arg293 and Arg297 contribute to RNA-binding by 
salt-bridge formation to the phosphate groups of the RNA. Interestingly, ceClp1 was shown to 
phosphorylate G1C2 with the same efficiency as longer single-stranded RNA oligonucleotides 
(Bernhard Loll, personal communication). To explain this biochemical observation, the 
structure of ceClp1 bound to a longer RNA oligonucleotide (G1A2A3A4) was solved (Figure 
3.1.5 C). The structure model was refined to an R-factor of 18.5 % and an Rfree of 22 % at a 
resolution of 2.4 Å. An unambiguous electron density was visible for all nucleotides. Binding 
modes between the dinucleotide and the oligonucleotide were found to be virtually identical 
(r.m.s.d.: of 1.2 Å, Figure 3.1.5 D). After the first two nucleotides, no additional interaction 
contacts between RNA and ceClp1 were observed. Interestingly, a water molecule (W41) 
visible in the dinucleotide structure interacts with the 3’-hydroxyl group of C2 and thereby 
indicates the putative position of the 3’-5’ bridging phosphate group of a longer substrate 
(Figure 3.1.5 A). Indeed, the position of the bridging phosphate group found in the 
oligonucleotide crystal structure is identical to the position of W41. The second phosphate 
group forms a salt bridge to Arg297. The Watson-crick base pairing interfaces of the 

























 base (C2). 
ion colored a




e in the fav




















































s (red) are s
lasp betwee












m +5 kT/e in
3A4. The ult

















The 2‘-hydroxyl group of the ultimate base is recognized by a hydrogen bond formed 
with the main chain carbonyl of a threonine residue (Thr191, RNA-sensor). This hydrogen 
bond could be an explanation for hsClp1’s ability to discriminate single stranded RNA against 
single stranded DNA88. Interestingly, based on the oligonucleotide conformation, one could 
model an ideal double stranded A-form RNA bound to ceClp1 without any steric hindrance 
by superposition with the single stranded RNA (Figure 3.1.6 A). The modeled double-strand 
also displays no steric clashes for the model of longer double stranded RNA as a linear 
substrate. In contrast to the 5’-acceptor strand, the modeled complementary strand showed no 
contact with the protein except when substrates with a 3’-overhang were used (Figure 3.1.6 
B). In conclusion, these two crystal structures explain Clp1’s ability to phosphorylate both 
single stranded and double stranded RNA substrates88 (see 3.2.2). 
Although the interactions of ceClp1 with the RNA backbone as well as the 
base-stacking interaction imposed no sequence specificity for the RNA substrate, the effect of 
sequence variation on RNA-binding was verified. For this, the dinucleotide U1G2 was soaked 
into crystals of ceClp1 and the third structural model of ceClp1 bound to RNA was obtained. 
This crystal structure was refined to an R-factor of 20.2 % and an Rfree of 25 % at a resolution 
of 2.1 Å (Figure 3.1.7). The guanosine and the uracile nucleotides of both dinucleotide bound 
structures were found to be virtually identical positioned (Figure 3.1.7 A and B), mostly 
through the clasp-like binding mechanism and interactions with the sugar phosphate 
backbone. Furthermore, both crystal structures showed unspecific Watson Crick-like 
hydrogen bonds. However, the penultimate base of the U1G2 structure was flipped away into a 
syn-conformation and thus did not perfectly stack with the ultimate base (Figure 3.1.7 B). The 
observation of a syn- instead of an anti-conformation of the penultimate base of U1G2 is most 
likely an artifact due to the use of dinucleotides. For longer nucleotides, the penultimate base 
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The ATP binding site was characterized using the ternary complex structure of ceClp1 bound 
to an ATP molecule and Mn2+ ion. This structure was refined to an R-factor of 18.2 % and an 
Rfree of 23.5 % at a resolution of 2.3 Å (Figure 3.1.8). Electron density for the ATP ligand was 
unambiguously identified within the active site region. In contrast to the RNA-binding site, 
the ATP molecule binds to the conserved P-loop motif (Figure 3.1.8) that is formed at the 
interface between NtD and PNK domain. Interestingly, ceClp1 showed substantial differences 
in the ATP-binding site when compared to all other previously described PNKs51,52. Whereas, 
in all other PNKs42,51,52 the P-loop is part of a solvent-exposed, open-ended channel, the ATP 
binding site of ceClp1 is shielded by NtD. More precisely, the ATP binding pocket is not 
completely obstructed by NtD. Instead, a channel is created at the interdomain boundary of 
NtD and the PNK (Fig. 3.1.8; ATP/ADP exchange channel). This cleft might enable 
ATP/ADP exchange during catalysis. The triphosphate moiety of the ATP molecule is bound 
in a narrow channel that is traversing the core of the PNK domain. The wall of this mainly 
positively charged channel is formed by residues of the classical P-loop motif, the LID 
module that contains conserved arginine residues (Arg288 and Arg293) and a catalytic 
divalent metal cofactor that is octahedrally coordinated. Although the ATP-Mn2+ structure 
showed a distorted octahedral coordination sphere of the divalent metal cofactor, it was 
complete in crystal structures of ceClp1 in complex with an Mg2+ ion. The octahedral 
coordination sphere of the Mg2+ ion is formed by the hydroxyl group of Thr128, which is the 
only direct interaction with protein and metal cofactor. The remaining sites of the octahedron 
were occupied by two non-bridging - and -phosphate oxygen atoms and three water 
molecules (W1, W2, and W3). The metal-coordinating water molecules are held in place by 
hydrogen bonds between W1 and the oxygen atom of side-chain Asn229, and W2, which 
forms a hydrogen bond to the oxygen atom of Asp151 (Figure 3.1.9). 
The nucleobase and ribose of the ATP molecule are bound in the domain interface of 
NtD and PNK domain. Within this pocket, N6 of the adenine ring forms a hydrogen bond to 
the side-chain oxygen atom of Glu16. Furthermore, the nucleobase is at a perfect π-stacking 
orientation with the side chain of a phenylalanine (Phe39), which is part of NtD (Figure 
3.1.8). The 3’-hydroxyl group of the ribose moiety forms a hydrogen bond to the main-chain 
carbonyl of Arg56. The tri-phosphate moiety of the ATP molecule is held in place by 
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outwards from the active site prior to the phosphoryl transfer reaction. The LID arginines are 
involed in ATP-binding by interactions with their guanidinuim group and the oxygen atoms 
of the phosphate β- and γ-phosphate groups. 
 
3.1.9.2 Transition	state	mimic	with	aluminum	tetra	fluoride	
Our current understanding of phosphoryl transfer reactions is strongly supported by structural 
information on transition state analogs. It has been shown that aluminum, beryllium fluoride, 
and vanadate can be used as transition state analogs of the phosphoryl transfer reaction122,123. 
These analogs of a transferred phosphate group resemble transition state geometry and charge 
distribution121. This thesis provides the first crystal structure of a transition state analog 
obtained from a eukaryotic PNK (Figure 3.1.11). The crystal structure of a ternary complex 
(ADP-AlF4--Mg2+-G1C2) was refined to an R-factor of 22 % and an Rfree of 28 % at a 
resolution of 2.1 Å. Although bound AlF4- does not represent the trigonal bipyramidal 
transition state geometry, it is a good approximation and thus broadly accepted to represent a 
mimic of the transition state121. The octahedrally-coordinated aluminum atom interacts with 
four equatorial fluorine atoms, while the two axial positions are occupied by an oxygen atom 
of ADP’s β-phosphate and an oxygen atom of the attacking nucleophile, respectively. The 
aluminum atom is positioned between the donor oxygen atom of ADP and the acceptor 
oxygen atom of the polynucleotide with a distance of 2.1 Å and 2.2 Å, respectively. This 
apical coordination of donor and acceptor oxygen atoms suggests an in-line associative 
reaction mechanism similar to that for UMP kinases118. Negative charges of the penta 
coordinated transition state seem to be neutralized by electrostatic interactions with positively 
charged side chains of Lys127, Arg288, Arg293 and the Mg2+ ion. The observation of a 
charge-neutralized transition state is consistent with an associative reaction mechanism. 
Moreover, RNA and ADP move towards each other under the concerted actions of Lys127, 
Arg288, and Arg293. Importantly, the Walker A lysine no longer interacts with Gly121 and 
Thr230 but instead becomes activated. After the transfer of the phosphoryl group, RNA is 
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3.1.9.3 Product bound state with released RNA	
Since ceClp1 is active in the crystalline state, it was possible to obtain a product bound 
state by soaking crystals of ceClp1 with its substrates. After incubation of ceClp1 crystals 
with ATP and G1C2, crystal structures revealed electron density for an ADP molecule, while 
phosphorylated G1C2 was not present. This crystal structure represents the RNA released 
product bound state and was refined to an R-factor of 19 % and an Rfree of 24 % at a 
resolution of 2.0 Å (Figure 3.1.12). It is likely that the lack of electron density for 
phosphorylated RNA results from electrostatic repulsion between β-phosphate of ADP and 
5’-phosphorylated RNA. Interestingly, this crystal structure is characterized by a “switched 
off” Lys127 that points out of the active site, similar to the substrate-bound state. Lys127 
switches into an “arrested” state prior to and after the transition state. Furthermore, the latch 
arginines, Arg288 and Arg293, are reoriented. In a latch-catch mechanism, Arg293 of the LID 
module forms a salt bridge with Asp124 of the P-loop motif. In conclusion, ceClp1 seems to 
use a molecular gating mechanism characterized by a reorganization of the active site such 
that Lys127, Arg288, and Arg293 stabilize negative charges of the transferred phosphoryl 
group in the transition state, while preventing ATP hydrolysis in the absence of an RNA 
substrate. 
Interestingly, the arginines of the LID module seem to function in a latch-catch 
mechanism (Figure 3.1.11). These arginine latches are completely activated only in the 
transition state and form, together with Lys127, an environment that enables correct 
positioning and charge stabilization of the transition state (Figure 3.1.11). 
 
3.1.10 Summary	of	the	structural	results 
This thesis provides the first crystal structure of a eukaryotic PNK with a bound RNA 
oligonucleotide. Furthermore, high-resolution structures of enzymatically relevant states of 
ceClp1 were determined (AppNHp-Mg2+-G1C2, ADP-Mg2+-AlF4--G1C2, and ADP-Mg2+). 
Clp1’s RNA-specificity and RNA recognition are described based on these structural data. 
Additionally, it was possible to elucidate the phosphoryl transfer reaction mechanism. 
Interestingly, crystal structures showed a non-canonical Walker A lysine (Lys127) that seems 
to act as a molecular switch. Activation of this switch is achieved in the transition state 
complex while before and after the Walker A lysine is in an arrested conformation. In contrast 
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This section describes the biochemical characterization of ceClp1, which was shown to be a 
bona fide RPNK enzyme similar to previously described human orthologs88. In addition to 
high sequence conservation between these orthologs, ceClp1 and hsClp1 have identical RNA 
and DNA substrate specificities. The enzymatic characterization of ceClp1 showed that the 
dinucleotide is the minimal substrate for an efficient phosphoryl transfer. Intriguingly, in case 
of short RNA substrates (dinucleotides), ceClp1 shows a clear preference for purine against 
pyrimidine bases at the ultimate position, which is in accordance with the crystal structure. 
Furthermore, no basal ATPase activity or product inhibition could be measured for ceClp1, 
which suggested a highly regulated 5’-kinase activity. Moreover, the 5’-kinase reaction is 




An RPNK activity of ceClp1 was demonstrated using an in vitro phosphorylation assay with 
different RNA and DNA substrates. A comprehensive biochemical characterization of hsClp1 
revealed a strong preference for RNA substrates as the 5’-phosphate acceptor88. To compare 
the specificity of ceClp1 with hsClp1, the enzyme (2 µM) was incubated with different single 
stranded and double stranded oligonucleotides (0.1 mM), followed by a separation using 
denaturing PAGE. The control reactions with T4 PNK verified the differential electrophoretic 
mobility of phosphorylated oligonucleotide substrates (Fig. 3.2.1). In accordance with 
observations made for hsClp1, ceClp1 also discriminates single stranded RNA against single 
stranded DNA (Fig. 3.2.1 A). However, ceClp1 is able to phosphorylate double-strand 
nucleotide RNA and DNA substrates with blunt ends. But again, the efficiency is lower for 
double stranded DNA (Fig. 3.2.1 B). Similar results were obtained for double stranded RNA 
and double stranded DNA molecules with a 3’-overhang (Fig. 3.2.1 C). Interestingly, blunt 
ended double stranded RNA substrates showed higher phosphorylation efficiency when 
compared to double stranded RNA substrate with a 3’-overhang. Even though ceClp1 showed 
a clear preference for single stranded RNA and double stranded RNA, it also displayed a 
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reaction mixture containing 1 mM ATP and 0.5 mM of either G1C2 or U1G2 and pre-incubated 
for 15 minutes at 20°C. After this pre-incubation step, the reaction was started by addition of 
ceClp1 and then analyzed using a coupled calorimetric ATPase assay (Figure 3.2.2). Although 
ceClp1 showed a significant ATP turnover with both dinucleotides, phosphorylation of G1C2 
was much more efficient compared to U1G2 (Figure 3.2.2 A). After an initial lag phase, the 
ATP turnover of G1C2 and U1G2 reached its maximum velocity. The same experiment was 
performed with 0.5 mM of adenosine- and cytosine 3’-monophosphate (3’-AMP and 
3’-CMP). Neither with 3’-AMP nor with 3’-CMP, was an ATP turnover measured. Results of 
these measurements, together with structural data (see 3.1.7), suggest that correct binding to 
the clasp motif of ceClp1 is impaired for 3’-nucleoside monophosphate substrates. These 
conclusions are further supported by results obtained for hsClp1 and the mammalian PNK, 
which also showed no 5’ -kinase activity on 3’ -nucleoside monophosphates85,88. Currently, 
only T4 PNK, has been shown to phosphorylate 3’-nucleoside monophosphates46. Therefore, 
a control reaction was performed with T4 PNK under identical conditions. As expected, in the 
presence of 3’-AMP and 3’-CMP, enzymatic activity could be detected for T4 PNK (Figure 
3.2.2 B).  
Michaelis-Menten kinetics of ceClp1 were measured at varying dinucleotide (G1C2 
and U1G2) concentrations. The Vmax and Km values were obtained by fitting to a 
Michaelis-Menten equation (Equation 1.2). At saturating ATP concentration of 1 mM, ceClp1 
(0.2 µM) showed an apparent kcat of 2.5 s-1 and Km of 103.0 μM for G1C2, and a kcat of 2.3 s-1 
and Km of 1122.0 μM for U1G2 (Figure 3.2.3). These kinetic data suggest that under saturating 
dinucleotide concentrations, ceClp1 displays similar turnover rates for G1C2 and U1G2. 
However, a tenfold higher Km value indicated a much lower substrate affinity for U1G2. This 
can be explained by the crystal structure of ceClp1 bound to the U1G2, which shows an 
imperfect base-stacking interaction mimic of the ultimate base (U1) to Trp233. The 
penultimate base (G2) is flipped into a syn-conformation. However, the position of the 5’-
hydroxyl was in ideal hydrogen bonding distance to Gly232 and Asp151. These structural 
details are reflected in the increased Km value and identical turnover rates at saturation. 
Interestingly, experiments with longer nucleotide substrate revealed similar Michaelis-Menten 
constants for G1C2. Michaelis-Menten values of a penta nucleotide G1A2A3A4A5 determined 
under identical conditions as in this thesis exhibited a kcat = 2.2 s-1 and Km = 99.0 μM (Bernard 
Loll). As suggested by the protein-RNA interaction profile seen in the crystal structure of 
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3.2.3 Characterization of ceClp1’s 5’-kinase activity 
Using an enzymatically coupled spectroscopic ATPase assay, it was possible to characterize 
the substrate specificity of ceClp1. However, these experiments have the drawback that the 
quantification of enzymatic activity only relies on conversion of ATP to ADP. Therefore, a 
second experimental setup for an in vitro phosphorylation assay was used to support kinetic 
data obtained with the coupled-enzyme assay (Figure 3.2.5). The second assay is based on a 
MonoQ anion exchange chromatography protocol designed for binding and baseline 
separation of ceClp1’s 5’-kinase reaction substrates from products. 
Steady-state kinetics were measured under limiting enzyme concentrations (0.2 µM) in 
a reaction mixture containing saturating ATP (1 mM) and 0.5 mM G1C2 concentrations. For 
the second assay, ceClp1 (2µM) was incubated with ATP and G1C2, each in a concentration 
of 250 µM, at 25 °C for 2 hours. Due to a change in ionic net charge after the phosphoryl 
transfer reaction, substrates and products can be separated by anion exchange 
chromatography. To assess possible basal ATPase activity of ceClp1, both assays were 
performed in absence of G1C2, which showed no basal ATPase activity (Figure 3.2.5 A and 
B). However, after the addition of RNA a significant ATP turnover and an accumulation of 
the reaction products ADP and 5’P-G1C2 were detected. Using the phosphorylation assay, it 
was also tested if the net charge of the RNA is modified in an ATP-independent manner, 
which was not the case (Figure 3.2.6 C). Furthermore, it was possible to show that the kinase 
reaction proceeds in a one-to-one stoichiometry. Therefore, ceClp1 was incubated with ATP 
(500 µM) in two-fold excess compared to the G1C2 concentration. Observed ATP turnover 
was proportional to the conversion of G1C2 to 5’P-G1C2. ceClp1 shows neither unstimulated 
basal ATPase activity nor RNA-stimulated basal ATPase activity (Figure 3.2.5 D).  
In addition, ceClp1 was tested for product inhibition using the coupled calorimetric 
ATPase assay at varying G1C2 concentrations. ATP turnover rates were followed by the 
decrease in absorbance at 340 nm due to oxidation of NADH (Figure 3.2.6). The reaction rate 
of each measurement obtained under varying G1C2 concentration was plotted and analyzed. 
Maximum velocity of the reaction was reached after an initial lag phase. Although a slight 
decrease of ATP turnover rates at the end of the reaction was measured, it is possible that this 
decrease is due to dilution effects. Consistent with this hypothesis the weaker decrease of 
ATP turnover rates at higher G1C2 concentration. Thus, ceClp1 seems to show no product 
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3.2.5 Summary of the enzymology studies  
Altogether, the biochemical characterization demonstrates that ceClp1 is an RPNK with 
identical substrate specificity as hsClp1. Although ceClp1 is able to phosphorylate RNA and 
DNA polynucleotides, it shows a much higher affinity for RNA substrates. Furthermore, 
steady-state kinetics revealed that ceClp1 requires at least a dinucleotide for an efficient 
phosphoryl transfer reaction. Intriguingly, the dinucleotide G1C2 represents the minimal 
substrate for ceClp1, showing similar Michaelis-Menten kinetics as measured for an 
oligonucleotide substrate. However, in case of the dinucleotide substrate, ceClp1 displays a 
preference for purine against pyrimidine bases at the ultimate position as indicated by the 
tenfold increased Km of U1G2 compared to G1C2. Interestingly, the characterization of ceClp1 
reveals no basal ATPase activity, and moreover, ceClp1 seems to show no product inhibition. 
In contrast to other PNKs42,51,52, ceClp1 functions as a quasi-unidirectional enzyme with no 





Previous mutagenesis studies in our lab allowed the identification of a number of catalytically 
important residues for ceClp1 enzyme activity (Table 3.3.1). Conservative and non-
conservative mutations were introduced based on the sequence alignment of Clp1 from higher 
eukaryotes (Figure 3.1.1). As expected, hot spots for mutation sites were found in highly 
conserved regions like the P-loop motif, the Walker B motif, the LID module and the clasp. 
This characterization focused in particular on conserved residues of the PNK domain (Pro122, 
Thr123, Asp124, Asp151, Glu154, Asp235, Arg288, and Arg293) to show their potential 
involvement in enzyme catalysis. In addition, in this thesis structure-guided site-directed 
mutagenesis and biochemical methods were employed to supplement the previous mutational 
characterization of ceClp1 (Table 3.3.1). The wild-type protein and mutated protein-variants 
(K127A, K127R, and W233A) were expressed and purified as described for crystallization 
experiments (see 3.1.2, Figure 3.3.1 A). Subsequently, purified protein variants were 
characterized for their 5’-kinase activity using an enzymatically coupled spectroscopic 
ATPase assay (Figure 3.3.1 B). Steady state kinetics were measured under limiting protein 




destabilizing effects by the mutation, the thermodynamic stability of all mutant variants was 
verified by determining the apparent melting point (Tm) using circular dichroism 
spectroscopy. All mutant variants revealed no significant differences compared to the wild 
type (Figure 3.3.1 C and D). 
Since the Walker A lysine (Lys127) of the P-loop showed a non-canonical “switched-
off” conformation prior to and after the transition state, this residue was considered to be part 
of a molecular gating mechanism. Therefore, the structure-function relation was examined by 
a conservative substitution. Lys127 was replaced with an arginine residue and a 
non-conservative alanine substitution. Based on ATPase activity, Lys127 proved to be 
essential for enzyme catalysis since K127R was abolished in enzymatic activity. It is possible 
that K127R mutation might interfere with the bifurcated binding of the β- and γ- phosphates 
groups by Lys127 at the transition state structure (Figure 3.1.10). Non-conservative mutations 
of the Walker A lysine have previously been shown to abolish enzyme activity of P-loop 
kinases and therefore serve as a negative control88. As predicted, the 5’-kinase activity of the 
K127A variant was abolished (Figure 3.3.1 B).  
The crystal structure of ceClp1 bound to an RNA substrate (Figure 3.1.5) showed a 
base stacking interaction mimic between the indol group of Trp233 and the ultimate base of 
the substrate. Alanine substitution of Trp233 (W233A) also abolished the 5′-kinase activity of 
ceClp1. Therefore, the π-stacking interaction between Trp233 and the ultimate nucleobase 












































































 protein, 1 m
variants K1






d by an add
elusive so 
ase activity






ntrol for an 
olding is an
temperature














s (Tm) of ceC
aining the a

































Table 3.3.1 Michaelis-Menten steady-state constants of wild type ceClp1 and mutated variants 
using G1C2 as substrate. Titration experiment was performed at a constant concentration of 1 mM 
ATP and 0.2 μM ceClp1. 
Enzyme KM [μM] kcat [s-1] Function Reference 
ceClp1wt 109 2.5  This thesis 
ceClp1P122A 187 1.8 A P-loop residue involved in main chain 
interactions with the nucleoside triphosphate. 
* 
ceClp1P122S 691 3.1 * 
ceClp1T123A residual activity A P-loop residue involved in main chain 
interactions with the nucleoside triphosphate. 
* 
ceClp1T123S 185 0.9 * 
ceClp1D124A 1764 1.3 A P-loop residue that interacts via its side chain 
with both residue Arg288 and the ATP molecule. 
* 
ceClp1D124Q no activity * 
ceClp1D124N 612 0.3 * 
ceClp1K127A no activity The Walker A lysine is usually involved in 
coordination of the β- and γ-phosphate groups. 
This thesis 
ceClp1K127R no activity This thesis 
ceClp1D151A no activity The catalytic base is involved in the deprotonation of the 5’-OH group. 
* 
ceClp1Q154A no activity The side chain of this residue interacts with 5’→3’ phosphate group of the ultimate base. 
* 
ceClp1W233A no activity This residue is involved in a base stacking interaction mimic with the ultimate base. 
This thesis 
ceClp1D235A 244 3.2 The side chain of this residue forms a salt bridge interaction with Arg261.  
* 
ceClp1R288A no activity The side chain of this residue is involved in charge 
neutralization of phosphate groups. 
* 
ceClp1R288K 276 2.2 * 
ceClp1R293L no activity The side chain of this residue is involved in charge 
neutralization of phosphate groups. 
* 
ceClp1R293K residual activity * 
* Mutant variants were measured from Bernhard Loll. 
 
3.3.2.1 	Purification	of	truncated	ceClp1	protein	variants	
To functionally and structurally characterize truncation variants of ceClp1, different 
constructs were designed and cloned via a standard cloning procedure into bacterial pET21a 
and pET28b expression vectors. Resulting sequence-verified clones were transformed into E. 
coli BL21-CodonPlus(DE3)-RIL cells allowing for an IPTG-inducible overexpression. The 




then further purified. In contrast to full-length protein, truncated variants appeared to be rather 
insoluble.  
For NtD truncation variants, two constructs were designed in which the polypeptide 
chain was truncated in or after the N-terminal helix α1 (ceClp1ΔN85 and ceClp1ΔN107, 
Figure 3.1.1). Whereas purification of ceClp1ΔN85 was unsuccessful due to solubility 
problems, purification of ceClp1ΔN107 could be optimized by co-expression with a protein 
variant coding for NtD (ceClp1ΔC104). Both domains bound to each other and formed a 
complex that could be separated after immobilization on a Talon affinity column. Although 
the purification procedure included a single Talon affinity chromatography step, samples were 
highly homogeneous as confirmed by SDS-PAGE. Separated proteins were subsequently 
tested for 5’-kinase activity, which was measured by an enzymatically coupled spectroscopic 
ATPase assay. 
Similar to the truncation experiments characterizing the functional importance of the 
NtD, three protein variants with a C-terminal deletion were designed. The truncations were 
located in helix α7 (ceClp1ΔC288, ceClp1ΔC304, and ceClp1ΔC310). Since only 
ceClp1ΔC310 was soluble, this mutated protein variant was purified and 5’-kinase activity 
was measured. Furthermore, ceClp1ΔC310 was also co-expressed with a protein variant 




Truncation of the NtD as well as CtD were tested enzymatically using two different IPTG 
inducible truncation variants ceClp1ΔN107 and ceClp1ΔC310 (Figure 3.3.2 A and B). Based 
on the ATP-bound crystal structure of ceClp1, specific interactions between the nucleobase 
and conserved residues of NtD were identified (Figure 3.1.8). The ATP molecule interacts, 
via hydrogen bonds, with the side chain of Glu16 and the main chain carbonyl of Arg56. 
Furthermore, the nucleobase forms a stacking interaction with Phe36 of the NtD. In addition, 
there is evidence for domain flexibility of the NtD. Sequence alignment of the eukaryotic 
Clp1 protein family shows a highly conserved putative hinge region within the loop 
connecting NtD with PNK domain Gly114 (Figure 3.1.1). This loop appears to be flexible, 
since a poorly defined electron density was observed for the crystal structure. Therefore, it 
seemed plausible that deletion of NtD should affect ceClp1 5’-kinase activity. Indeed, as a 




(Figure 3.3.2 C). Moreover, the mutated protein variant ceClp1ΔN107 was prone to 
aggregation, probably due to solvent-exposed hydrophobic patches. Interestingly, 5’-kinase 
activity of the ceClp1ΔN107 variant was restored by -complementation with the NtD (Figure 
3.3.2 A). 
In contrast to NtD, residues of CtD do not contribute to the active site of ceClp1 
(Figure 3.1.4). However, the CtD and the PNK domain are linked downstream after helix α7. 
Helix α7 contains the LID module and a conserved arginine residue (Arg297, Figure 3.1.1). 
The LID module has an important role in charge stabilization of the transition state. 
Furthermore, Arg293 and Arg297 form hydrogen bonds to the backbone phosphates of the 
RNA substrate (Figure 3.1.5). Therefore, a truncation within helix α7 (ceClp1ΔC288) was 
expected to affect ceClp1 enzymatic activity, since three highly conserved arginine residues 
(Arg288, Arg293, and Arg297) are removed. Indeed, truncation at the end of helix α7 
(ceClp1ΔC310) diminished ceClp1 5’-kinase activity (Figure 3.3.2 D). It is likely that the LID 
module becomes disordered upon removal of CtD. To restore 5’-kinase activity of 
ceClp1ΔC310, the CtD (ceClp1ΔN315) was trans-complemented. However, no kinase 
activity could be detected and thus trans-complementation is not sufficient to overcome a 
possible distortion of helix α7. 
In conclusion, both additional domains affect ceClp1 5’-kinase activity. Whereas NtD 
is involved in ATP binding and shows domain flexibility, CtD could have a function in the 




In conclusion, the site-directed mutagenesis experiments demonstrate the importance of the 
Walker A lysine for enzyme catalysis. Furthermore, the clasp-motif was identified, which is a 
novel feature of members of the Clp1 protein family.  
To complement these mutagenesis experiments, ceClp1 was further characterized by 
deletion of the additional domains NtD and CtD. Based on these experiments, NtD seems 
highly flexible and this flexibility might be involved in a regulatory function. So far, the 
function of the CtD remained largely elusive. However, initial results suggest an important 
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In the course of this thesis it could be shown that Clp1 orthologs from higher eukaryotes 
represent novel types of RPNKs. Based on their structural conservation, Clp1 homologs 
define a subfamily of RPNKs, the Clp1 protein family. These RPNPs show broad 
phylogenetic distribution and can be found in all three kingdoms of life86-88,95,96. Although 
structurally conserved, members of the Clp1 protein family were shown to be involved in 
different RNA maturation pathways86-88,90. This functional difference might be due to 
additional NtD and CtD flanking the PNK domain. The NtD and CtD are novel structural 
elements that are unique to the Clp1 protein family. Truncation experiments with the NtD and 
CtD revealed their importance for ceClp1’s enzymatic activity. Based on these observations, 
it is conceivable that either the in vivo function or the regulation of enzymatic activity in Clp1 
depends on the structural dynamics of the additional domains, which will be discussed in 
more detail in the following sections. 
 
4.1.1 Sequence	conservation	of	the	Clp1	protein	family	
ceClp1 is a multidomain protein composed of a central PNK domain flanked by additional 
NtD and CtD (Figure 3.1.1 and Figure 3.1.4). While hsClp1 contributes to mRNA processing, 
tRNA splicing and RNAi88,90,92, the homologous proteins Nol9 and Grc3 were shown to 
participate in rRNA maturation86,87,115,116. Based on a sequence alignment, these enzymes 
define the Clp1 protein family, owing the highest degree of conservation within the PNK 
domain. The PNK domain is subdivided into an ATP- and an RNA-binding site. The 
sequence alignment also revealed four conserved structural motifs associated with substrate 
binding and enzyme catalysis (Figure 3.1.1 and Figure 4.1.1). The most prominent motifs for 
PNK are the P-loop motif GxxxxGK[T/S] and the Walker B motif DxxQ113,114. However, 
Clp1 revealed two additional motifs that are only conserved among members of the Clp1 
protein family. These motifs are the LID module (RxxxxR) and the clasp motif (TxGW). The 
sequence of the central PNK domain seems to be conserved throughout all kingdoms of 
life86,88,95,96 (Figure 4.1.1). Jain and Shuman95 identified a Clp1 archaeal homolog from 
Pyrococcus horikoshii that displays similar RNA-specificity in vitro as shown for ceClp1 




homolog in Nitrosococcus halophilus (nhClp1) Figure (4.1.1). This “GTPase or GTP-binding 
protein-like protein” (CP001798.1) shows a high sequence homology to the PNK and the CtD 
domain. Interestingly, in both the bacterial (nhClp1) as well as the archaeal Clp1 (phClp1) 
homolog, no evidences for an NtD are found. Furthermore, Nol9 and Grc3 display sequence 
alterations in their NtD and CtD. On the basis of these observations it can be assumed that the 
additional NtD and CtD have a regulatory or a recruiting function important for the different 
in vivo functions of the enzymes. Since only Clp1 homologs in eukaryots consist of an NtD, it 
is likely that an NtD with a putative regulatory function was acquired during evolution to add 
an additional layer of regulation to its 5’-kinase activity. 
 
4.1.2 Putative	regulatory	function	of	the	additional	NtD	and	CtD	
With respect to the additional domains, ceClp1 is structurally different from all other 
previously described PNKs51,52,69. In contrast to the T4 PNK as well as the mPNK with an 
“open” ATP-binding site, the NtD of ceClp1 was covering its active site (Figure 4.1.2). The 
crystal structure of ceClp1 revealed interactions between the nucleobase and conserved 
residues of the NtD (Glu16, Phe38, and Arg56). Interestingly, the mPNK125 also shows these 
kinds of interactions, however, in case of ceClp1, the ATP binding site is completely 
obstructed from the NtD (Figure 3.1.4). Truncation experiments of the NtD and the CtD 
showed the importance of both domains for Clp1’s 5’-kinase activity (Figure 3.3.2). 
Truncation of both domains abolished the enzymatic activity, but only through 
trans-complementation of the NtD ceClp1’s enzyme activity could be restored (Figure 
3.3.2 C). These experiments suggest a function of the NtD in ATP-binding. This hypothesis is 
consistent with the conservation of the ATP-binding site within higher eukaryotes showing 
parts of the NtD that interact with ATP to be highly conserved (Figure 4.1.2). The CtD is 
distal to the α-helical LID module and truncation of the CtD might affect the alignment of the 
catalytically relevant arginine residues of the LID module. Thus, the CtD appeared to be 
important for the correct positioning of the LID module. A structural comparison of the NtD 
and CtD with structures of the PDB database revealed structural homology of the NtD to the 
FHA domain (r.m.s.d: 2 Å) of the mPNK. The FHA domain is involved in factor 
recruitment42 by recognition of the phosphorylated forms of the two scaffold proteins XRCC1 
and XRCC4. Although both the FHA domain and the NtD were composed of a two β-sheet 
sandwich, the topological arrangement of the strands is different (Figure 3.1.4). Moreover, a 
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these homologs also show a high sequence homology of the PNK domain (Figure 4.1). 
Therefore, it is likely that structural features of the PNK domain are responsible for the 
specificity of the 5’-nucleotide substrate in vitro. These structural features mainly depend on 
the clasp motif and on the “RNA-sensor” recognizing the 2’-hydroxyl group at the ultimate 
position of the RNA. 
Similar to previously described PNKs42,51,52, ceClp1 interacts with its RNA substrate 
via a combination of several interactions including the backbone phosphates, sugars, and the 
bases themselves (Figure 3.1.6). In ceClp1, the ultimate nucleobase stacks on the hydrophobic 
side chains of Trp233. This residue is part of the clasp motif. Mutation of Trp233 to alanine 
effectively impaired enzyme catalysis (Figure 3.3.1). Even though the clasp motif represents a 
novel consensus sequence (TxGW) for RNA-binding, it is highly conserved throughout 
higher eukaryotes (Figure 3.1.1). This binding mechanism is similar to other PNKs42,51,52. The 
T4 PNK and the mPNK have similar hydrophobic interaction pockets. In contrast to Trp233, 
nucleobases are stacked to smaller hydrophobic residues (Val135 and Val477, T4 PNK and 
mPNK, respectively42,51,52). Another unique feature of Clp1’s clasp motif is a hydrogen bond 
formed by Gly232 to the 5’-hydroxyl group of the RNA substrate. Thereby, the clasp ensures 
that the RNA is positioned in a favored 3'-endo form and in anti-conformation (Figure 3.1.5). 
Interestingly, despite their similarities in binding of the ultimate nucleobase, ceClp1 
shows a major difference in the orientation of the nucleotide, which is inverted compared to 
the other PNKs. This observation suggests convergent evolution of Clp1 in the protein family 
of PNKs. Despite these differences, the binding mechanism of the 3’-5’ bridging phosphate 
groups seems to be conserved within the protein family of PNKs42,51,52. Again, Clp1, T4 PNK, 
and mPNK show a similar binding mechanism. In each case the first two 3’-5’ bridging 
phosphate groups are recognized by conserved arginine residues (Arg34, Arg38 and Arg395, 
Arg432; T4 PNK and mPNK, respectively). The structure described in this thesis shows a 
hydrogen bond as well as salt bridges between three conserved residues (Gln154, Arg293, and 
Arg297) and the first two 3’-5’ bridging phosphate groups being important for binding 
(Figure 3.1.5). The importance was also shown by comprehensive mutational analysis 
(Table 3.3.1). In this respect, ceClp1 is similar to the majority of RNA-binding enzymes, 
which are interacting more with the bound 3’-5’ bridging phosphate groups and less with the 
nucleobase or the nucleosugar159. However, in contrast to the T4 PNK, which was previously 
described to phosphorylate 3’-nucleoside monophosphates46, ceClp1 was unable to use this 
substrate (Figure 3.2.2). Although structurally similar, ceClp1 imposes different requirements 




PNKs reveals slight differences in binding of the first bridging phosphate. T4 PNK126 shows 
the tightest interaction with its substrate compared to ceClp1 and mPNK125. Thus, ceClp1 and 
mPNK require dinucleotides or oligonucleotides for efficient binding42,85. 
As shown by experiments aiming at identification of the preferred substrate 
(Figure 3.2.1), Clp1 can discriminate single-stranded RNA against single-stranded DNA88. 
The possible explanation for this selectivity of ceClp1 is the main chain carbonyl of Thr191 
that forms a hydrogen bond to the ribose 2'-hydroxyl group of the ultimate nucleotide (Figure 
3.1.5). In contrast to published crystal structures of the other PNKs42,51,52, Clp1 is the only 
PNK that recognizes the 2’-hydroxyl group. Interestingly, Clp1’s RNA-sensor only 
recognizes the 2’-hydroxyl group at the ultimate position of the substrate. Phosphorylation 
assays showed that replacing the RNA molecule at the ultimate position by a 
desoxyribonucleotide abolishes hsClp1’s ability to phosphorylate synthetic substrate in 
hsClp188. Strikingly, it was possible to model an ideal double-stranded A-form RNA bound to 
ceClp1 without any steric hindrance by superposition with the single-stranded RNA observed 
in the crystal structure. This model explains why Clp1 is able to phosphorylate both, single as 
well as double-stranded RNAs88. The modeled double-stranded RNA has no steric clashes 
when modeled for longer double-stranded RNA substrates (Figure 3.1.6 A). In contrast to the 
5’-acceptor strand, the complementary strand shows no contact with the protein, except for 
modeled substrates with a 3’-overhang (Figure 3.1.6 B). The continuous base stacking 
interaction of the 3’overhang of RNA has to be interrupted to become accommodated in the 
RNA-binding site of ceClp1. This observation might explain why double-stranded 
3’-overhang RNA and DNA substrates were phosphorylated less efficiently compared to blunt 
end substrates. In conclusion, the crystal structures of Clp1 bound to RNA explain the 
selectivity for both single-stranded and double-stranded RNA substrates. 
 
4.3 Phosphoryl	transfer	reaction	
Even though extensive biochemical and structural studies are available on the phosphoryl 
transfer reactions of P-loop kinases, relatively little is known about the functional mechanism 
in PNKs. This thesis provides structural data about the first reaction trajectory of PNKs. 
Crystal structures of ceClp1 were trapped during enzyme catalysis such as an inhibited 
substrate bound state, a transition state analog and a product bound state. By comparing 
ceClp1’s active site geometry between ground state and transition state, a general model for 






Similar to other P-loop kinases, the active site of ceClp1 is formed by residues of the classical 
P-loop motif, a LID module, and a catalytic Mg2+ ion19. Interestingly, although the Walker A 
lysine of the P-loop is classically involved to interact in a bifurcated manner with the β- and 
γ-phosphate groups of ATP113, ceClp1’s Lys127 was captured outside the active site in both 
the inhibited substrate bound state (Figure 3.1.10) and the product bound state (Figure 3.1.12). 
In the ground state, Lys127 was “switched-off”, whereas in the crystal structure of the 
transition state analog, Lys127 was switched into an active conformation (Figure 3.1.11). The 
“switched-on” Lys127 assists in enzyme catalysis by stabilizing the developing negative 
charges on the leaving group (3.1.11). The observation of the “arrested” Walker A lysine is in 
contrast to the prevailing structural and biochemical dogma underlying the Walker A 
lysine113. To exclude the possibility that ceClp1 belongs to the special group of Walker A 
lysine independent P-loop kinases160-163, the functional role of Lys127 for enzyme catalysis 
was tested by non-conservative and conservative point mutations. Both mutant variants, 
K127A and K127R (Table 3.3.1), were abolished in their enzymatic activity similar to the 
results of Walker A lysine mutants in hsClp188. This suggests that Clp1 uses a substrate gating 
mechanism composed of the catalytically important Lys127, which is switched on and off 
during enzyme catalysis. A highly regulated RPNK would have been in accordance with the 
biochemical characterization on ceClp1 revealing a quasi-unidirectional 5’-kinase (Figure 
3.2.8) that suppresses futile side reactions (Figure 3.2.5 and 3.2.6). 
Despite this exclusive substrate-gating mechanism, the overall architecture of 
ceClp1’s active site resembles those of previously described P-loop kinases19. The proposed 
model of the phosphoryl transfer reaction follows a mechanism of a classical associative 
transition state124 (Figure 3.1.11). The enzymatic reaction starts with the nucleophilic attack of 
the deprotonated 5’-hydroxyl group. Based on the crystal structure of ceClp1, the 5’-hydroxyl 
group of the bound RNA was shown to be in an ideal hydrogen bonding distance to the 
catalytic base (Asp151). Asp151 is proposed to abstract the proton of the attacking 
5’-hydroxyl group prior to the nucleophilic attack on the -phosphate group of ATP. In fact, 
mutation of Asp151 to alanine abrogates the phosphoryl transfer reaction in ceClp1 (Table 
3.3.1), supporting the function of Asp151 as general base. This result could also be shown for 
the equivalent residue in hsClp197. The function of the general base is highly conserved in 




Asp396 in T4 PNK and mPNK, respectively) reveals a highly conserved aspartate residue in 
ideal hydrogen bonding distance to the respective position. Additionally, site-directed 
mutagenesis showed the catalytical importance of those general bases164. Also, the 
5’-hydroxyl group of the incoming nucleophile is further recognized by a hydrogen bond from 
the main-chain amide of Gly232 (see 3.1.5), which is part of the RNA-binding clasp. Gly232 
might contribute to the correct position of the attacking nucleophile. 
On the opposite site of the attacking nucleophile, an ATP molecule is positioned 
enabling an efficient in-line phosphoryl transfer reaction. The phosphate groups of the ATP 
interact with the main-chain amide of the residues of the P-loop motif. In addition to the 
P-loop motif, an α-helical LID module together with a catalytic Mg2+ ion assists in charge 
neutralization of the ATP phosphate groups19,113. In the inhibited substrate bound state, two 
catalytically important arginine residues Arg288 and Arg293 form salt-bridges between their 
guanidinium groups and the oxygen atoms of the β- and γ-phosphate groups. Both arginine 
residues are essential for enzyme catalysis. Non-conservative mutations (R288A, R293L) led 
to an effectively abolished enzymatic activity, to an extent comparable with the Walker A 
lysine mutant K127A (Table 3.3.1). Interestingly, conservative mutation to lysine (R288K 
and R293K) revealed functional differences between Arg288 and Arg293. Whereas R288K 
appeared to be slightly impaired in kinase activity, R293K was inactivity (Table 3.3.1). Thus, 
Arg288 seems to be important for neutralizing the developing negative charges during the 
transition state. However, Arg293 additionally contributes to the RNA-binding site by its 
guanidinium group interacting in a bidendate mode forming salt-bridges to the phosphate 
groups of the ATP as well as the 5’-3’ bridging phosphate of the RNA (Figure 3.1.5). 
A LID module with conserved arginine residues is a common feature of the reaction 
mechanism in PNKs and P-loop kinases in general19. A structural comparison with other 
described PNKs identified similar arginine residues in T4 PNK51,164 (Arg122 Arg126). 
Mutagenesis studies on T4 PNK showed the enzymatic relevance of those arginine residues as 
it was shown for ceClp1165. Based on the contribution of Arg293 in RNA-binding it is 
suggested that this residue also plays a role in RNA release after the phosphoryl transfer 
reaction. In the inhibited substrate bound state Arg293 interacts with the phosphate backbone 
of the RNA, but in the crystal structures of ceClp1 bound to ADP and G1A2A3A4, Arg293 is 
reoriented that breaks up the salt bridge to the RNA. Arg293 is captured by Asp124 as shown 
for the product bound state. Both residues function in a latch-catch mechanism166. 
Mutagenesis studies on Asp124 showed additionally the enzymatic relevance of the 
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Table 4.3.1. Table of proteins owing a non-conventional Walker A lysine 
residue. 













Non-conventional Walker A lysine structures 
1 XXXX 
ceClp1 polynucleotide 





kinase 2.10 GPTDVGKT 121-128 (A) ADP 
no nucleotide 
interactions 
3 3A1S FeoB iron iransporter 1.50 GCPNVGKT 23-30 (A) GDP 
no nucleotide 
interactions 
4 4FCW ClpB 2.35 GPTGVGKT 595-602 (A) ADP 
no nucleotide 
interactions 
5 2XTN Gimap2 1.90 GKTGTGKS 29-36 (A) GTP 
no nucleotide 
interactions 









30-37 (A) GDP 
no nucleotide 
interactions 
8 3QKT Rad50 ABC-ATPase 1.90 GQNGSGKS 30-37 (A) ANP γ-phosphate 
9 3PXN 
Kinesin family member 





ABCB10 2.85 GPSGSGKS 527-534 (A) ACP β-phosphate 
11 3NH9 ABCB6 2.10 GPSGAGKS 623-630 (A) ATP β-phosphate 
12 2JDI F1-ATPase 1.90 GDRQTGKT 169-176 (A) ANP β-phosphate 
13 2VHJ 
P4 protein from 
bacteriophage 1.80 GKGNSGKT 130-137 (A) ADP 
no nucleotide 
interactions 




DNA mismatch repair 
protein MutS 2.20 GPNMGGKS 614-621 (A) ADP 
no nucleotide 
interactions 
16 3RC3 Helicase Suv3 2.08 GPTNSGKT 10-17 (A) ANP 
no nucleotide 
interactions 
17 1NKS Adenylate kinase 2.57 GIPGVGKS 8-15 (F) ADP 
no nucleotide 
interactions 
18 1R6B ClpA 2.25 GPTGVGKT 495-502 (X) ADP 
no nucleotide 
interactions 
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According to the Protein Data Bank, there are a significant number of other P-loop 
kinases with similar Walker-A lysine residues in an “arrested” conformation (Table 4.3.1). 
However, the relevance of this peculiar conformation of the Walker A lysine remained 
undiscussed in the literature until now. A superposition of these crystal structures shows that 
the triphosphate groups do not align and that their position is rather randomly distributed 
(Figure 4.3.2 A). In contrast, triphosphate groups of cases in which the Walker A lysine 
adopts the classical conformation, these phosphate groups are virtually identically oriented 
(Figure 4.3.2 B). The eukaryotic Clp1 seems to have evolved a sophisticated mechanism to 
repress basal site activities. One of these regulatory mechanisms is the newly identified 
Walker A lysine functioning as a molecular door step. Also the latch-catach (Arg293-Asp124) 
seems to play an important role in enzyme catalysis. These two active site regulation elements 
are in addition to the function of the NtD and CtD that were also schon to affect enzymatic 




This work provides new structural, functional and mechanistic insights into the Clp1 protein 
family. RPNK represents a novel type of PNK that shows high sequence conservation within 
the PNK domain. Based on a sequence alignment, four different consensus sequences were 
identified that are characteristic for this protein family. The clasp motif together with the 
“RNA-sensor” enables Clp1 to contribute to different RNA maturation pathways as a 
recurrent linker. Both single-stranded RNA as well as double stranded DNA and RNA is 
accommodated in the RNA-binding site of this protein family86-88,95. Whereas hsClp1 is part 
of the mRNA, tRNA and RNAi maturation pathways88,92, Nol987 and Grc386,115,116 are also 
involved in rRNA maturation. It could therefore be suggested that the different RNA 
maturation pathways are interconnected to a global RNA metabolism controlled by the Clp1 
protein family. Currently, knowledge about in vivo substrates of Clp1 is limited90. However, 
the structural data of this thesis could provide the framework to understand RNA-recognition 
and RNA-specificity in more detail. In combination with a detailed biochemical 





In contrast to previously described PNKs, Clp1 also consists of additional NtD and 
CtD which are flanking the PNK domain. The initial characterization of truncation variants 
presented in this work suggests that the enzymatic activity of ceClp1 is directly affected by 
these additional domains. Future experiments aiming towards a better understanding of the 
function of these additional domains will be reasonable. The additional NtD and CtD possibly 
serve as a protein-protein interaction interface. This interface may regulate Clp1’s enzymatic 
activity by structural dynamics in domain flexibility. Possible strategies to test this 
protein-induced regulation include a phosphorylation assay measured in the presence of 
putative interaction partners. A possible candidate for initial screening experiments could be 
Pcf11, the interaction partner of the CFIIm89. 
 
4.4.2 Functional	diversity	within	the	Clp1	protein	family 
Although ceClp1 and scClp1 show a high sequence similarity, both enzymes are functionally 
different. scClp1 is enzymatically inactive94, however, still able to bind ATP and ADP 
molecules94,98-100. ATP binding seems to be required for factor recruitment during the 
cleavage and polyadenylation reaction of RNA polymerase II transcripts98-100. The crystal 
structure of ceClp1 revealed structural features involved in enzyme catalysis. A comparison 
between scClp1 and ceClp1 shows that catalytically important residues are 
non-conservatively mutated, the P-loop motif, however, remains unaffected. Apparently, 
scClp1 has lost its PNK activity during evolution, whereas structural integrity of scClp1 still 
requires ATP-binding98-100. The bioinformatical and structural data suggest catalytically 
important residues that are required for active Clp1 homologs. These sequence profiles can be 
used to search for other active variants in all three kingdoms of life. A functional comparison 
of Clp1 homologs from all kingdoms of life may allow new insights into RNA metabolism 
such as underestimated cross-connection between mRNA, tRNA, rRNA, and RNAi. 
 
4.4.3 The central dogma of the Walker A lysine has to be reconsidered 
The presented structural work of ceClp1 provides a detailed model of the phosphoryl transfer 
reaction mechanism for a RPNK. Based on structural conservation of the PNK domain, this 
proposed model is generally applicable for PNKs from all three kingdoms of life. 




mechanism168. The Walker A lysine of ceClp1 functions as a door step that prevents futile 
ATP hydrolysis. This observation is consistent with experiments showing that ceClp1 has no 
basal ATPase activity and only functions in the forward reaction as a quasi unidirectional 
enzyme. Eukaryotic Clp1 seems to have evolved a sophisticated mechanism to repress basal 
site activities. Interestingly, a detailed search in the PDB database identified several other 
proteins showing a putative molecular switch for the Walker A lysine. In all cases, the Walker 
A lysine is in an arrested conformation, however, a corresponding activated structure is 
missing. Therefore, it will be an exciting task to further characterize a representative selection 
of these proteins. The identification of other Walker A lysine switches would argue for a 
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Primer name Sequence [5’→3’] 
ceClp1-pET21a-For CGA AGC ATC ATA TGA GCG AGG AGA ATG 
TTC 
ceClp1-pET21a-Rev GAG TGC GGC CGC TCG TTT TAT TTG ATC AT 
ceClp1-pET28b-For CG AAG CAT CAT ATG AGC GAG GAG AAT GTT 
C 
ceClp1-pET28b-Rev TGC GGC CGC TCA TCG TTT TAT TTG ATC ATC 
ceClp1ΔN314-pET21a_For GCA TTA GCC ATA TGC CAT TCA CAT TTG ACG 
Quikchange Primers 
Primer name Sequence [5’→3’] 
ceClp1ΔN107-pET21a(ΔHis)-For ATC TTG ATG ATC AAA TAA AAC GAT AGC TTG 
CGG CCG C 
ceClp1ΔN107-pET21a(ΔHis)-Rev GCG GCC GCA AGC TAT CGT TTT ATT TGA TCA 
TCA AGA T 
ceClp1ΔC104-pET28b-For GAA GAA GAG AGA GGA ACA GTA GGC TGG 
AAA CTC GAA TAA G 
ceClp1ΔC104-pET28b-Rev CTT ATT CGA GTT TCC AGC CTA CTG TTC CTC 
TCT CTT CTT C 
ceClp1ΔC310-pET28b-For TCT ACG GAA CCC GTG CCT AGA ATC TCT ACC 
CAT TCA C 
ceClp1ΔC310-pET28b-Rev GTG AAT GGG TAG AGA TTC TAG GCA CGG GTT 
CCG TAG A 
ceClp1K127A-pET21a-For 






GGA GAC TGT GGT TGC TCC GAC GTC CGT TGG 
T 
ceClp1K127R-pET28b-For 
ACC AAC GGA CGT CGG AAG AAC CAC AGT 
CTC C 
ceClp1K127R-pET28b-Rev 









Single stranded RNA 5’-GCG AGA CAG UGU GAC UUU GG-3’ 
Double stranded RNA with 
blunt ends 
5’-GCG AGA CAG UGU GAC UUU GG-3’ 
5’-CCA AAG UCA CAC UGU CUC GC-3’ 
Double stranded RNA with a 
single stranded 3’-overhang 
5’-GAG ACA GUG UGA CUU UGG AC-3’ 
5’-CCA AAG UCA CAC UGU CUC GC-3’ 
Single stranded DNA 5’-GCG AGA CAG TGT GAC TTT GG-3’ 
Double stranded DNA with 
blunt ends 
5’-GCG AGA CAG TGT GAC TTT GG-3’ 
5’-CCA AAG TCA CAC TGT CTC GC-3’ 
Double stranded DNA with a 
single stranded 3’-overhang 
5’-GAG ACA GTG TGA CTT TGG AC-3’ 




















Conventional Walker A lysine: Substrate bound state structures




Pnkp-Hen1 RNA repair 
system 2.00 GSSGSGKS 15-22 (A) ATP 
β- and γ-
phosphate 





tRNA(Sec) kinase 1.80 GLPGVGKS 11-18 (A) ANP 
β- and γ-
phosphate 




Rab11 in complex with 
FIP3 Rab-binding 
domain  1.75 
GDSGVGKS 





protein 1 nucleotide 
binding domain 1 1.50 
GQVGCGKS 
678-685 (A) ATP 
β- and γ-
phosphate 






transporter complex 2.20 
GPSGCGKS 
36-43 (A) ANP 
β- and γ-
phosphate 





ATPase domain 1.55 GEFGSGKT 138-145 (A) ATP 
β- and γ-
phosphate 
12 2GCO RhoC 1.40 GDGACGKT 12-129 (A) GNP 
β- and γ-
phosphate 

















248-255 (A) ATP 
β- and γ-
phosphate 





GlcV, the ABC-ATPase 
of the glucose ABC 
transporter 1.95 
GPSGAGKT 
38-45 (A) ANP 
β- and γ-
phosphate 




Kinesin Eg5 motor 
domain 2.00 GQTGTGKT 105-112 (A) ANP 
β- and γ-
phosphate 
20 3EW9 RADA recombinase 2.40 GMFGSGKT 105-112 (A) ANP 
β- and γ-
phosphate 
        
Conventional Walker A lysine: Transition state analogue structures 
1 3SR0 Adenylate kinase 1.57 GPPGAGKG 7-14 (A) AlF4- 
β- and γ-
phosphate 
2 5UKD UMP/CMP kinase 1.90 
GGPGSGKG 
13-20 (A) Al F3 
β- and γ-
phosphate 















transporter 2.30 GPSGCGKS 36-43 (A) AlF4- 
β- and γ-
phosphate 




RhoA with GAP 
domain of ArhGAP20  1.65 GDGACGKT 12-19 (A) Al F3 
β- and γ-
phosphate 




MglA in complex with 
MglB 2.20 GPGLSGKT 19-26 (A) AlF4- 
β- and γ-
phosphate 







324-341 (A) Al F3 
β- and γ-
phosphate 
13 4ANJ Myosin VI  2.60 GESGAGKT 151-158 (A) AlF4- 
β- and γ-
phosphate 
14 3BH7 RP2-Arl3 complex 1.90 GLDNAGKT 24-31 (A) AlF4- 
β- and γ-
phosphate 
15 1W9I Myosin II 1.75 
GESGAGKT 




Gyp1 TBC domain in 
complex with Rab33 
GTPase 2.26 
GDSNVGKT 






17 1W0J F1-ATPASE  2.20 GGAGVGKT 155-162 (D) Be F3 
β- and γ-
phosphate 




RGS1 in complex with 
the activated Gi alpha 
1  2.55 
GAGESGKS 
40-47 (A) AlF4- 
β- and γ-
phosphate 
20 1GRN CDC42-GAP complex 2.10 GDGAVGK 10-17 (A) Al F3 
β- and γ-
phosphate 
        
Conventional Walker A lysine: Product bound state structures 
1 4GP6 
Pnkp-Hen1 RNA repair 





3'-phosphatase 2.15 GFPGAGKS 371-378 (A) APD 
β- and γ-
phosphate 









Kinesin family member 




Kif1A Motor Domain 
1.55 
GQTGAGKS 
96-130 (A) ADP 
β- and γ-
phosphate 
7 2IYQ Shikimate kinase 1.8 GLPGSGKS 9-16 (A) ADP 
β- and γ-
phosphate 




KIFC3 motor domain 
1.85 
GSERVGKS 





2 1.8 GGTASGKS 27-34 (A) ADP 
β- and γ-
phosphate 





ATPase domain 1.88 GEFGSGKT 138-145 (A) ADP 
β- and γ-
phosphate 
13 4A14 KIF7 1.6 GQTGSGKT 91-98 (A) ADP 
β- and γ-
phosphate 
14 3REF EhRho1 1.95 GDGAVGKT 27-34 (A) GDP 
β- and γ-
phosphate 





kinase 1 1.95 
GVTNSGKT 
10-17 (A) ADP 
β- and γ-
phosphate 








SV40 large T antigen 
helicase domain 1.95 GPIDSGKT 426-433 (A) ADP 
β- and γ-
phosphate 
19 1F6B  SAR1 1.7 GLDNAGKT 32-39 (A) GDP 
β- and γ-
phosphate 








ADP    adenosine-5’-diphosphate 
ATP   adenosine-5’-triphosphate 
A.U.    arbitrary units 
AppNHp  adenyl-5’-(,-imido)triphosphate 
BSA    bovine serum albumin 
CD    circular dichroism 
C-terminus   carboxy terminus 
CtD   C-terminal domain 
DNA    deoxyribonucleic acid 
DTE    dithioerythritol 
EDTA    ethylenediaminetetraacetic acid 
G1C2   guanylyl(3′→5′)cytidine 
GTP    guanosine-5’-triphosphate 
HEPES   4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
IPTG    isopropyl β-D-1-thiogalactopyranoside 
LB    lysogeny broth medium 
mRNA   messenger ribonucleic acid 
NADH   nicotinamide adenine dinucleotide 
N-terminus   amino terminus 
NtD   N-terminal domain 




PCR    polymerase chain reaction 
PDB    protein database 
PEP    phosphoenolpyruvate 
PNK   Polynucleotide kinase 
RNA    ribonucleic acid 
RPNK   RNA-specific PNK 
rRNA   ribosomal RNA 
TCEP    (tris(2-carboxyethyl)phosphine) 
TEMED   tetramethylethylenediamine 
Tris    tris(hydroxymethyl)aminomethane 
tRNA   transfer RNA 
SDS    sodium dodecyl sulfate 
SDS-PAGE   sodium dodecyl sulfate polyacrylamide gel electrophoresis 
U1G2   urylyl-(3’→5’)guanosine 
UV    ultra violet light 
% w/v    mass/volume percentage 
% v/v    volume/volume percentage 
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